Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PRAXAIR INCFinancial_Report.xls
EX-31.02 - RULE 13A-14(A) CERTIFICATION - PRAXAIR INCpx-2015331xex3102.htm
EX-12.01 - COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES - PRAXAIR INCpx-2015331xex1201.htm
EX-32.02 - SECTION 1350 CERTIFICATION - PRAXAIR INCpx-2015331xex3202.htm
EX-31.01 - RULE 13A-14(A) CERTIFICATION - PRAXAIR INCpx-2015331xex3101.htm
EX-32.01 - SECTION 1350 CERTIFICATION - PRAXAIR INCpx-2015331xex3201.htm

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to
PRAXAIR, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
1-11037
 
06-1249050
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
39 OLD RIDGEBURY ROAD, DANBURY, CT
 
06810-5113
(Address of principal executive offices)
 
(Zip Code)
(203) 837-2000
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
ý
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
¨
Smaller reporting company
 
¨
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨    No  ý
At March 31, 2015, 288,310,190 shares of common stock ($0.01 par value) of the Registrant were outstanding.
 



INDEX
 
 
PART I - FINANCIAL INFORMATION
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
Condensed Consolidated Balance Sheets - Praxair, Inc. and Subsidiaries March 31, 2015 and December 31, 2014 (Unaudited)
 
 
 
 
Condensed Consolidated Statements of Cash Flows - Praxair, Inc. and Subsidiaries Three Months Ended March 31, 2015 and 2014 (Unaudited)
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
Item 5.
 
 
 
Item 6.
 
 
 
 





PRAXAIR, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Millions of dollars, except per share data)
(UNAUDITED)
 
 
Quarter Ended March 31,
 
2015
 
2014
SALES
$
2,757

 
$
3,026

Cost of sales, exclusive of depreciation and amortization
1,530

 
1,726

Selling, general and administrative
299

 
326

Depreciation and amortization
277

 
285

Research and development
24

 
23

Other income (expense) - net
(4
)
 
9

OPERATING PROFIT
623

 
675

Interest expense - net
44

 
46

INCOME BEFORE INCOME TAXES AND EQUITY INVESTMENTS
579

 
629

Income taxes
162

 
176

INCOME BEFORE EQUITY INVESTMENTS
417

 
453

Income from equity investments
11

 
9

NET INCOME (INCLUDING NONCONTROLLING INTERESTS)
428

 
462

Less: noncontrolling interests
(12
)
 
(14
)
NET INCOME - PRAXAIR, INC.
$
416

 
$
448

PER SHARE DATA - PRAXAIR, INC. SHAREHOLDERS
 
 
 
Basic earnings per share
$
1.44

 
$
1.52

Diluted earnings per share
$
1.43

 
$
1.51

Cash dividends per share
$
0.715

 
$
0.65

WEIGHTED AVERAGE SHARES OUTSTANDING (000’s):
 
 
 
Basic shares outstanding
289,143

 
294,195

Diluted shares outstanding
291,652

 
297,253

The accompanying notes are an integral part of these financial statements.


3


PRAXAIR, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Millions of dollars)
(UNAUDITED)
 
 
Quarter Ended March 31,
 
2015
 
2014
NET INCOME (INCLUDING NONCONTROLLING INTERESTS)
$
428

 
$
462

 
 
 
 
OTHER COMPREHENSIVE INCOME (LOSS)
 
 
 
Translation adjustments:
 
 
 
Foreign currency translation adjustments
(644
)
 
(20
)
Reclassifications to net income

 
(3
)
Income taxes
(34
)
 
(9
)
Translation adjustments
(678
)
 
(32
)
Funded status - retirement obligations (Note 10):
 
 
 
Retirement program remeasurements
9

 
2

Reclassifications to net income
19

 
13

Income taxes
(10
)
 
(5
)
Funded status - retirement obligations
18

 
10

Derivative instruments (Note 5):
 
 
 
Current quarter unrealized gain (loss)

 
3

Reclassifications to net income

 

Income taxes

 
(1
)
Derivative instruments

 
2

TOTAL OTHER COMPREHENSIVE INCOME (LOSS)
(660
)
 
(20
)
 
 
 
 
COMPREHENSIVE INCOME (LOSS) (INCLUDING NONCONTROLLING INTERESTS)
(232
)
 
442

Less: noncontrolling interests
18

 
(12
)
COMPREHENSIVE INCOME (LOSS) - PRAXAIR, INC.
$
(214
)
 
$
430

The accompanying notes are an integral part of these financial statements.


4


PRAXAIR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Millions of dollars)
(UNAUDITED)
 
 
March 31, 2015
 
December 31, 2014
ASSETS
 
 
 
Cash and cash equivalents
$
117

 
$
126

Accounts receivable - net
1,751

 
1,796

Inventories
535

 
551

Prepaid and other current assets
323

 
366

TOTAL CURRENT ASSETS
2,726

 
2,839

Property, plant and equipment (less accumulated depreciation of $11,551 in 2015 and $11,857 in 2014)
11,593

 
11,997

Goodwill
3,010

 
3,121

Other intangible assets - net
588

 
603

Other long-term assets
1,206

 
1,242

TOTAL ASSETS
$
19,123

 
$
19,802

LIABILITIES AND EQUITY
 
 
 
Accounts payable
$
813

 
$
864

Short-term debt
623

 
587

Current portion of long-term debt
2

 
2

Other current liabilities
897

 
1,037

TOTAL CURRENT LIABILITIES
2,335

 
2,490

Long-term debt
8,771

 
8,669

Other long-term liabilities
2,454

 
2,457

TOTAL LIABILITIES
13,560

 
13,616

Commitments and contingencies (Note 11)

 

Redeemable noncontrolling interests
170

 
176

Praxair, Inc. Shareholders’ Equity:
 
 
 
Common stock $0.01 par value, authorized - 800,000,000 shares, issued 2015 and 2014 - 383,230,625 shares
4

 
4

Additional paid-in capital
3,980

 
3,994

Retained earnings
11,668

 
11,461

Accumulated other comprehensive income (loss)
(3,815
)
 
(3,185
)
Less: Treasury stock, at cost (2015 - 94,920,435 shares and 2014 - 93,969,017 shares)
(6,819
)
 
(6,651
)
Total Praxair, Inc. Shareholders’ Equity
5,018

 
5,623

Noncontrolling interests
375

 
387

TOTAL EQUITY
5,393

 
6,010

TOTAL LIABILITIES AND EQUITY
$
19,123

 
$
19,802

The accompanying notes are an integral part of these financial statements.


5


PRAXAIR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Millions of dollars)
(UNAUDITED)
 
 
Three Months Ended March 31,
 
2015
 
2014
OPERATIONS
 
 
 
Net income - Praxair, Inc.
$
416

 
$
448

Noncontrolling interests
12

 
14

Net income (including noncontrolling interests)
428

 
462

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
277

 
285

Deferred income taxes
14

 
23

Share-based compensation
7

 
15

Working capital:
 
 
 
Accounts receivable
(50
)
 
(136
)
Inventory
(6
)
 
(16
)
Prepaid and other current assets
2

 
20

Payables and accruals
(66
)
 
(116
)
Pension contributions
(11
)
 
(9
)
Long-term assets, liabilities and other
(87
)
 
8

Net cash provided by operating activities
508

 
536

INVESTING
 
 
 
Capital expenditures
(397
)
 
(393
)
Acquisitions, net of cash acquired
(5
)
 
(124
)
Divestitures and asset sales
2

 
66

Net cash used for investing activities
(400
)
 
(451
)
FINANCING
 
 
 
Short-term debt borrowings (repayments) - net
38

 
(80
)
Long-term debt borrowings
753

 
847

Long-term debt repayments
(501
)
 
(303
)
Issuances of common stock
44

 
49

Purchases of common stock
(235
)
 
(286
)
Cash dividends - Praxair, Inc. shareholders
(207
)
 
(191
)
Excess tax benefit on share-based compensation
14

 
20

Noncontrolling interest transactions and other
(6
)
 
(140
)
Net cash (used for) provided by financing activities
(100
)
 
(84
)
Effect of exchange rate changes on cash and cash equivalents
(17
)
 
5

Change in cash and cash equivalents
(9
)
 
6

Cash and cash equivalents, beginning-of-period
126

 
138

Cash and cash equivalents, end-of-period
$
117

 
$
144

The accompanying notes are an integral part of these financial statements.

6


INDEX TO NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Notes to Condensed Consolidated Financial Statements - Praxair, Inc. and Subsidiaries (Unaudited)
 


7


PRAXAIR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. Summary of Significant Accounting Policies
Presentation of Condensed Consolidated Financial Statements - In the opinion of Praxair, Inc. (Praxair) management, the accompanying condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods presented and such adjustments are of a normal recurring nature. The accompanying condensed consolidated financial statements should be read in conjunction with the notes to the consolidated financial statements of Praxair, Inc. and subsidiaries in Praxair’s 2014 Annual Report on Form 10-K. There have been no material changes to the company’s significant accounting policies during 2015.
Accounting Standards Implemented in 2015
The following standards were effective for Praxair in 2015 and their adoption did not have a significant impact on the condensed consolidated financial statements:
Reporting Discontinued Operations – In April 2014, the FASB issued updated guidance on the reporting and disclosures of discontinued operations. The new guidance requires that the disposal of a component of an entity be reported as discontinued operations only if the action represents a strategic shift that will have a major effect on an entity’s operations and financial results, and would require expanded disclosures. The adoption of this guidance did not have a significant impact on the condensed consolidated financial statements.

Accounting Standards to be Implemented

Revenue Recognition – In May 2014, the FASB issued updated guidance on the reporting and disclosure of revenue. The new guidance requires the evaluation of contracts with customers to determine the recognition of revenue when or as the entity satisfies a performance obligation, and would require expanded disclosures. This guidance will be effective for Praxair beginning in the first quarter 2017 and includes several transition options. Praxair is in the early stages of reviewing the new guidance and will provide updates on the expected impact to Praxair in future filings, as determined.
Accounting for Share-based Compensation - In June 2014, the FASB issued updated guidance on the accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. Praxair does not expect this requirement to have a significant impact on the condensed consolidated financial statements. This guidance will be effective for Praxair beginning in the first quarter 2016, with early adoption optional.
Presentation of Debt Issuance Costs – In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs. The new guidance requires debt issuance costs to be classified as debt rather than deferred charges within the condensed consolidated financial statements. Praxair does not expect this requirement to have a significant impact on the condensed consolidated financial statements. This guidance will be effective for Praxair beginning in the first quarter 2016 on a retrospective basis, with early adoption optional.

Reclassifications – Certain prior years’ amounts have been reclassified to conform to the current year’s presentation.

8


2. Acquisitions
2015 Acquisitions

During the three months ended March 31, 2015 Praxair had acquisitions totaling $5 million. This was due primarily to the acquisition of a packaged gases business in South America.
2014 Acquisitions

During the three months ended March 31, 2014 Praxair had acquisitions totaling $124 million. These consisted of the acquisitions of an industrial gases business in Italy, several packaged gases businesses in North and South America and an equity investment in the Middle East. These transactions resulted in goodwill and other intangible assets of $43 million and $29 million, respectively (see Note 8).
3. Supplemental Information
Inventories
The following is a summary of Praxair’s consolidated inventories:
(Millions of dollars)
March 31,
2015
 
December 31,
2014
Inventories
 
 
 
Raw materials and supplies
$
194

 
$
200

Work in process
48

 
52

Finished goods
293

 
299

Total inventories
$
535

 
$
551


Long-term receivables
Long-term receivables are not material and are largely reserved. Such long-term receivables are included within other long-term assets in the condensed consolidated balance sheets and totaled $40 million and $43 million at March 31, 2015 and December 31, 2014, respectively. These amounts are net of reserves of $40 million and $48 million, respectively. The amounts in both periods relate primarily to government receivables in Brazil and other long-term notes receivable from customers. Collectability is reviewed regularly and uncollectible amounts are written-off as appropriate. The account balance changes during 2015 were primarily due to foreign exchange rate movements.


9


4. Debt
The following is a summary of Praxair’s outstanding debt at March 31, 2015 and December 31, 2014:
(Millions of dollars)
March 31,
2015
 
December 31,
2014
SHORT-TERM
 
 
 
Commercial paper and U.S. bank borrowings
$
536

 
$
514

Other bank borrowings (primarily international)
87

 
73

Total short-term debt
623

 
587

LONG-TERM
 
 
 
U.S. borrowings (U.S. dollar denominated unless otherwise noted)
 
 
 
4.625% Notes due 2015 (a)

 
500

3.25% Notes due 2015 (b, d)
405

 
408

0.75% Notes due 2016 (b)
400

 
400

Floating Rate Notes due 2017 (e)
150

 

5.20% Notes due 2017
325

 
325

1.05% Notes due 2017
400

 
400

1.20% Notes due 2018
500

 
500

1.25% Notes due 2018 (c, d)
485

 
481

4.50% Notes due 2019 (c)
599

 
599

1.90% Notes due 2019
500

 
500

1.50% Euro-denominated notes due 2020 (c)
641

 
722

4.05% Notes due 2021 (c)
499

 
499

3.00% Notes due 2021 (c)
497

 
497

2.45% Notes due 2022 (c)
598

 
598

2.20% Notes due 2022 (c)
499

 
499

2.70% Notes due 2023 (c)
499

 
499

2.65% Notes due 2025 (c, e)
398

 

1.625% Euro-denominated notes due 2025 (c)
532

 
599

3.55% Notes due 2042 (c, e)
666

 
466

Other
4

 
4

International bank borrowings
168

 
167

Obligations under capital leases
8

 
8

 
8,773

 
8,671

Less: current portion of long-term debt
(2
)
 
(2
)
Total long-term debt
8,771

 
8,669

Total debt
$
9,396

 
$
9,258

 
(a)
In March 2015, Praxair repaid $500 million of 4.625% notes that became due.
(b)
Classified as long-term because of the company’s intent to refinance this debt on a long-term basis and the availability of such financing under the terms of an existing $2.5 billion long-term credit facility.
(c)
Amounts are net of unamortized discounts.
(d)
March 31, 2015 and December 31, 2014 include a $15 million and $14 million fair value increase, respectively, related to hedge accounting. See Note 5 for additional information.
(e)
On February 5, 2015, Praxair issued $150 million of floating rate notes that bear interest at the Federal funds effective rate plus 0.33% due 2017, $400 million of 2.65% fixed rate notes due 2025 and $200 million of 3.550% fixed rate notes due in 2042. The proceeds were used for general corporate purposes, including the repayment of outstanding indebtedness.

10


5. Financial Instruments
In its normal operations, Praxair is exposed to market risks relating to fluctuations in interest rates, foreign currency exchange rates, energy costs and to a lesser extent precious metal prices. The objective of financial risk management at Praxair is to minimize the negative impact of such fluctuations on the company’s earnings and cash flows. To manage these risks, among other strategies, Praxair routinely enters into various derivative financial instruments (“derivatives”) including interest-rate swap and treasury rate lock agreements, currency-swap agreements, forward contracts, currency options, and commodity-swap agreements. These instruments are not entered into for trading purposes and Praxair only uses commonly traded and non-leveraged instruments.
There are three types of derivatives that the company enters into: (i) those relating to fair-value exposures, (ii) those relating to cash-flow exposures, and (iii) those relating to foreign currency net investment exposures. Fair-value exposures relate to recognized assets or liabilities, and firm commitments; cash-flow exposures relate to the variability of future cash flows associated with recognized assets or liabilities, or forecasted transactions; and net investment exposures relate to the impact of foreign currency exchange rate changes on the carrying value of net assets denominated in foreign currencies.
When a derivative is executed and hedge accounting is appropriate, it is designated as either a fair-value hedge, cash-flow hedge, or a net investment hedge. Currently, Praxair designates all interest-rate and treasury-rate locks as hedges for accounting purposes; however, currency contracts are generally not designated as hedges for accounting purposes unless they are related to forecasted transactions. Whether designated as hedges for accounting purposes or not, all derivatives are linked to an appropriate underlying exposure. On an ongoing basis, the company assesses the hedge effectiveness of all derivatives designated as hedges for accounting purposes to determine if they continue to be highly effective in offsetting changes in fair values or cash flows of the underlying hedged items. If it is determined that the hedge is not highly effective, then hedge accounting will be discontinued prospectively.
Counterparties to Praxair’s derivatives are major banking institutions with credit ratings of investment grade or better and no collateral is required, and there are no significant risk concentrations. Management believes the risk of incurring losses on derivative contracts related to credit risk is remote and any losses would be immaterial.
The following table is a summary of the notional amount and fair value of derivatives outstanding at March 31, 2015 and December 31, 2014 for consolidated subsidiaries:
 
 
 
 
 
Fair Value
 
Notional Amounts
 
Assets
 
Liabilities
(Millions of dollars)
March 31,
2015
 
December 31,
2014
 
March 31,
2015
 
December 31,
2014
 
March 31,
2015
 
December 31,
2014
Derivatives Not Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
Currency contracts:
 
 
 
 
 
 
 
 
 
 
 
Balance sheet items (a)
$
2,431

 
$
2,427

 
$
16

 
$
5

 
$
46

 
$
13

Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
Interest rate contracts:
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps (b)
875

 
875

 
15

 
14

 

 

Total Derivatives
$
3,306

 
$
3,302

 
$
31

 
$
19

 
$
46

 
$
13

 
(a)
Assets are recorded in prepaid and other current assets, and liabilities are recorded in other current liabilities.
(b)
Assets are recorded in other current and other long term assets
Currency Contracts
Balance Sheet Items
Foreign currency contracts related to balance sheet items consist of forward contracts entered into to manage the exposure to fluctuations in foreign-currency exchange rates on recorded balance sheet assets and liabilities denominated in currencies other than the functional currency of the related operating unit. The fair value adjustments on these contracts are offset by the fair value adjustments recorded on the hedged assets and liabilities.
Forecasted Purchases
Foreign currency contracts related to forecasted purchases consist of forward contracts entered into to manage the exposure to fluctuations in foreign-currency exchange rates on forecasted purchases of capital-related equipment and services denominated

11


in currencies other than the functional currency of the related operating units. These forward contracts were designated and accounted for as cash flow hedges.
Net Investment Hedge

Praxair has designated the €600 million (641 million as of March 31, 2015) 1.50% Euro-denominated notes due 2020 and the €500 million ($532 million as of March 31, 2015) 1.625% Euro-denominated notes due 2025, as a hedge of the net investment position in its European operations. These Euro-denominated debt instruments reduce the company's exposure to changes in the currency exchange rate on investments in foreign subsidiaries with Euro functional currencies. Since the time the Euro-denominated notes were issued in 2014, exchange rate movements have reduced long-term debt by $274 million ($149 million of which was during the first quarter 2015), with the offsetting gain shown within the cumulative translation component of AOCI in the condensed consolidated balance sheets and the condensed consolidated statements of comprehensive income.
Interest Rate Contracts
Outstanding Interest Rate Swaps
At March 31, 2015, Praxair had $875 million notional amount of interest-rate swap agreements outstanding related to the $400 million 3.25% fixed-rate notes that mature in 2015 and to the $475 million 1.25% notes that mature 2018, which effectively convert fixed-rate interest to variable-rate interest. These swap agreements were designated as fair value hedges with the resulting fair value adjustments recognized in earnings along with an equally offsetting charge / benefit to earnings for the changes in the fair value of the underlying debt instrument. At March 31, 2015, $15 million was recognized as an increase in the fair value of these notes ($14 million at December 31, 2014).

Terminated Treasury Rate Locks
The following table summarizes the unrecognized gains (losses) related to terminated treasury rate lock contracts:
 
Year
Terminated
 
Original
Gain /
(Loss)
 
Unrecognized Gain / (Loss) (a)
(Millions of dollars)
March 31,
2015
 
December 31,
2014
Treasury Rate Locks
 
 
 
 
 
 
 
Underlying debt instrument:
 
 
 
 
 
 
 
$500 million 2.20% fixed-rate notes that mature in 2022 (b)
2012
 
$
(2
)
 
$
(1
)
 
$
(1
)
$500 million 3.00% fixed-rate notes that mature in 2021 (b)
2011
 
(11
)
 
(7
)
 
(8
)
$600 million 4.50% fixed-rate notes that mature in 2019 (b)
2009
 
16

 
7

 
8

$500 million 4.625% fixed-rate notes that mature in 2015 (b)
2008
 
(7
)
 

 

Total - pre-tax
 
 
 
 
$
(1
)
 
$
(1
)
Less: income taxes
 
 
 
 

 

After- tax amounts
 
 
 
 
$
(1
)
 
$
(1
)
 
(a)
The unrecognized gains / (losses) for the treasury rate locks are shown in accumulated other comprehensive income (“AOCI”) and are being recognized on a straight line basis to interest expense – net over the term of the underlying debt agreements. Refer to the table below summarizing the impact on the company’s consolidated statements of income and AOCI for current period gain (loss) recognition.
(b)
The notional amount of the treasury rate lock contracts are equal to the underlying debt instrument with the exception of the treasury rate lock contract entered into to hedge the $600 million 4.50% fixed-rate notes that mature in 2019. The notional amount of this contract was $500 million.









12


The following tables summarize the impacts of the company’s derivatives on the consolidated statements of income and AOCI:
 
Amount of Pre-Tax Gain (Loss)
Recognized in Earnings *
 
Quarter Ended March 31,
(Millions of dollars)
2015
 
2014
Derivatives Not Designated as Hedging Instruments
 
 
 
Currency contracts:
 
 
 
Balance sheet items
 
 
 
Debt-related
$
(79
)
 
$
17

Other balance sheet items
(6
)
 
3

Total
$
(85
)
 
$
20

* The gains (losses) on balance sheet items are offset by gains (losses) recorded on the underlying hedged assets and liabilities. Accordingly, the gains (losses) for the derivatives and the underlying hedged assets and liabilities related to debt items are recorded in the consolidated statements of income as interest expense-net. Other balance sheet items and anticipated net income gains (losses) are recorded in the consolidated statements of income as other income (expenses)-net.

The following table summarizes the impact of the company's derivatives designated as hedging instruments that impact AOCI:

Derivatives Designated as Hedging Instruments **
 
Quarter Ended
 
Amount of Gain  (Loss)
Recognized in AOCI
 
Amount of Gain  (Loss)
Reclassified from AOCI to the Consolidated Statement of
Income
(Millions of dollars)
March 31,
2015
 
March 31,
2014
 
March 31,
2015
 
March 31,
2014
Currency contracts:
 
 
 
 
 
 
 
Net Investment Hedge
$

 
$
(6
)
 
$

 
$

Less: income taxes

 
2

 

 

Total - Net of Taxes
$

 
$
(4
)
 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
 
**The gains (losses) on net investment hedges are recorded as a component of AOCI within foreign currency translation adjustments in the condensed consolidated balance sheets and the condensed consolidated statements of comprehensive income. The gains (losses) on forecasted purchases and treasury rate locks are recorded as a component of AOCI within derivative instruments in the condensed consolidated balance sheets and the condensed consolidated statements of comprehensive income. There was no ineffectiveness for these instruments during 2015 or 2014. The gains (losses) on net investment hedges are reclassified to earnings only when the related currency translation adjustments are required to be reclassified, usually upon sale or liquidation of the investment. The gains (losses) for interest rate contracts are reclassified to earnings as interest expense –net on a straight-line basis over the remaining maturity of the underlying debt. Net losses of less than $1 million are expected to be reclassified to earnings during the next twelve months.

6. Fair Value Disclosures
The fair value hierarchy prioritizes the input to valuation techniques used to measure fair value into three broad levels as follows:
Level 1 – quoted prices in active markets for identical assets or liabilities
Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes assets and liabilities measured at fair value on a recurring basis:

13


 
Fair Value Measurements Using
 
Level 1
 
Level 2
 
Level 3
(Millions of dollars)
March 31,
2015
 
December 31,
2014
 
March 31,
2015
 
December 31,
2014
 
March 31,
2015
 
December 31,
2014
Assets
 
 
 
 
 
 
 
 
 
 
 
Derivatives

 

 
$
31

 
$
19

 

 

Liabilities
 
 
 
 
 
 
 
 
 
 
 
Derivatives

 

 
$
46

 
$
13

 

 

The fair values of the derivative assets and liabilities are based on market prices obtained from independent brokers or determined using quantitative models that use as their basis readily observable market parameters that are actively quoted and can be validated through external sources, including third-party pricing services, brokers and market transactions. Investments are marketable securities traded on an exchange.
The fair values of cash and cash equivalents, short-term debt, accounts receivable-net, and accounts payable approximate carrying amounts because of the short maturities of these instruments. The fair value of long-term debt is estimated based on the quoted market prices for similar issues, which is deemed a level 2 measurement. At March 31, 2015, the estimated fair value of Praxair’s long-term debt portfolio was $8,977 million versus a carrying value of $8,773 million. At December 31, 2014, the estimated fair value of Praxair’s long-term debt portfolio was $8,753 million versus a carrying value of $8,671 million. Differences from carrying amounts are attributable to interest-rate changes subsequent to when the debt was issued.

7. Earnings Per Share – Praxair, Inc. Shareholders
Basic earnings per share is computed by dividing Net income – Praxair, Inc. for the period by the weighted average number of Praxair common shares outstanding. Diluted earnings per share is computed by dividing Net income – Praxair, Inc. for the period by the weighted average number of Praxair common shares outstanding and dilutive common stock equivalents, as follows:
 
Quarter Ended March 31,
 
2015
 
2014
Numerator (Millions of dollars)
 
 
 
Net income - Praxair, Inc.
$
416

 
$
448

Denominator (Thousands of shares)
 
 
 
Weighted average shares outstanding
288,748

 
293,692

Shares earned and issuable under compensation plans
395

 
503

Weighted average shares used in basic earnings per share
289,143

 
294,195

Effect of dilutive securities
 
 
 
Stock options and awards
2,509

 
3,058

Weighted average shares used in diluted earnings per share
291,652

 
297,253

Basic Earnings Per Share
$
1.44

 
$
1.52

Diluted Earnings Per Share
$
1.43

 
$
1.51

Stock options of 2,800,555 were antidilutive and therefore excluded in the computation of diluted earnings per share for the quarter ended March 31, 2015. There were no antidilutive shares for the quarter ended March 31, 2014.

14


8. Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the three months ended March 31, 2015 were as follows:
(Millions of dollars)
North
America
 
South
America
 
Europe
 
Asia
 
Surface
Technologies
 
Total
Balance, December 31, 2014
$
2,139

 
$
147

 
$
654

 
$
38

 
$
143

 
$
3,121

Acquisitions (Note 2)

 
2

 

 

 

 
2

Purchase adjustments & other

 

 

 

 

 

Foreign currency translation
(15
)
 
(31
)
 
(60
)
 

 
(7
)
 
(113
)
Balance, March 31, 2015
$
2,124

 
$
118

 
$
594

 
$
38

 
$
136

 
$
3,010

Praxair has performed its goodwill impairment tests annually during the second quarter of each year, and historically has determined that the fair value of each of its reporting units was substantially in excess of its carrying value (refer to Note 1 to the consolidated financial statements of Praxair's 2014 Annual Report on Form 10-K). As a result, no impairment was recorded. There were no indicators of impairment through March 31, 2015.
Changes in the carrying amounts of other intangibles for the three months ended March 31, 2015 were as follows:
(Millions of dollars)
Customer &
License/Use
Agreements
 
Non-compete
Agreements
 
Patents &
Other
 
Total
Cost:
 
 
 
 
 
 
 
Balance, December 31, 2014
$
693

 
$
37

 
$
47

 
$
777

Additions (Note 2)
2

 

 

 
2

Foreign currency translation
(9
)
 

 

 
(9
)
Other *

 
(1
)
 

 
(1
)
Balance, March 31, 2015
$
686

 
$
36

 
$
47

 
$
769

Less: Accumulated amortization
 
 
 
 
 
 
 
Balance, December 31, 2014
$
(147
)
 
$
(18
)
 
$
(9
)
 
$
(174
)
Amortization expense
(8
)
 
(3
)
 
(1
)
 
(12
)
Foreign currency translation
4

 

 

 
4

Other *

 
1

 

 
1

Balance, March 31, 2015
$
(151
)
 
$
(20
)
 
$
(10
)
 
$
(181
)
Net balance at March 31, 2015
$
535

 
$
16

 
$
37

 
$
588

* Other relates to the write-off of fully amortized assets.
There are no expected residual values related to these intangible assets. The remaining weighted-average amortization period for intangible assets is approximately 18 years.
Total estimated annual amortization expense is as follows:
(Millions of dollars)
 
Remaining 2015
$
35

2016
47

2017
41

2018
37

2019
35

Thereafter
393

 
$
588


15


9. Share-Based Compensation
Share-based compensation of $7 million ($5 million after-tax) and $15 million ($10 million after-tax) was recognized during the quarters ended March 31, 2015 and 2014, respectively. Expense amounts reflect current estimates of achieving performance targets relating to performance-based compensation. The expense was recorded primarily in selling, general and administrative expenses. There was no share-based compensation cost that was capitalized. For further details regarding Praxair’s share-based compensation arrangements and prior-year grants, refer to Note 15 to the consolidated financial statements of Praxair’s 2014 Annual Report on Form 10-K.
Stock Options
The weighted-average fair value of options granted during the quarter ended March 31, 2015 was $11.99 ($14.62 in the 2014 first quarter) based on the Black-Scholes Options-Pricing model. The decrease in grant date fair value year-over-year is primarily attributable to the decrease in volatility.

The following weighted-average assumptions were used to value the grants in 2015 and 2014 :
 
Three Months Ended March 31,
 
2015
 
2014
Dividend yield
2.2
%
 
2.0
%
Volatility
13.5
%
 
15.2
%
Risk-free interest rate
1.51
%
 
1.57
%
Expected term years
5

 
5

The following table summarizes option activity under the plans as of March 31, 2015 and changes during the three-month period then ended (averages are calculated on a weighted basis; life in years; intrinsic value expressed in millions):
 
Number of
Options  (000’s)
 
Average
Exercise Price
 
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding at January 1, 2015
10,981

 
$
89.02

 
 
 
 
Granted
1,565

 
128.38

 
 
 
 
Exercised
(664
)
 
60.68

 
 
 
 
Cancelled or Expired
(15
)
 
104.78

 
 
 
 
Outstanding at March 31, 2015
11,867

 
95.77

 
5.8
 
$
318

Exercisable at March 31, 2015
9,070

 
$
86.48

 
4.8
 
$
314

The aggregate intrinsic value represents the difference between the company’s closing stock price of $120.74 as of March 31, 2015 and the exercise price multiplied by the number of options outstanding as of that date. The total intrinsic value of stock options exercised during the quarter ended March 31, 2015 was $44 million ($49 million during the same period in 2014).
Cash received from option exercises under all share-based payment arrangements for the quarter ended March 31, 2015 was $40 million ($45 million for the same time period in 2014). The cash tax benefit realized from share-based compensation totaled $23 million for the quarter ended March 31, 2015, of which $14 million in excess tax benefits was classified as financing cash flows for the three months ended March 31, 2015 ($34 million cash tax benefit for the same period in 2014 of which $20 million represented excess tax benefit for the three months ended March 31, 2014).
As of March 31, 2015, $31 million of unrecognized compensation cost related to non-vested stock options is expected to be recognized over a weighted-average period of approximately 1 year.
Performance-Based and Restricted Stock Awards
During the three months ended March 31, 2015, the company granted performance-based stock units to employees which vest principally based on the third anniversary of their grant date. The actual number of shares issued in settlement of a vested award can range from zero to 200 percent of the target number of shares granted based upon the company’s attainment of specified performance targets at the end of a three-year period. Compensation expense related to these awards is recognized over the three-year performance period based on the fair value of the closing market price of the company’s common stock on the date of the grant and the estimated performance that will be achieved. Compensation expense will be adjusted during the three-year performance period based upon the estimated performance levels that will be achieved.

16


During the three months ended March 31, 2015, the company also granted restricted stock units to employees. The majority of the restricted stock units vest at the end of a three-year service period. Compensation expense related to the restricted stock units is recognized on a straight line basis over the vesting period.
The weighted-average fair value of performance-based stock and restricted stock units granted during the three months ended March 31, 2015 was $120.05 and $120.04, ($121.16 and $121.20 for the same period in 2014). This is based on the closing market price of Praxair’s common stock on the grant date adjusted for dividends that will not be paid during the vesting period.
The following table summarizes non-vested performance-based and restricted stock award activity as of March 31, 2015 and changes during the three months then ended (shares based on target amounts, averages are calculated on a weighted basis):
 
Performance-Based
 
Restricted Stock
 
Number  of
Shares
(000’s)
 
Average
Grant  Date
Fair Value
 
Number  of
Shares
(000’s)
 
Average
Grant  Date
Fair Value
Non-vested at January 1, 2015
833

 
$
109.09

 
307

 
$
106.63

Granted*
215

 
120.05

 
72

 
120.04

Vested
(225
)
 
103.16

 
(1
)
 
106.35

Cancelled
(15
)
 
112.60

 
(26
)
 
109.80

Non-vested at March 31, 2015
808

 
$
114.49

 
352

 
$
110.83


* Amounts for performance-based awards include an adjustment of 35 thousand shares relating to the actual payout of 2012 grants in 2015.
In addition to what is included in the table above, there are approximately 16 thousand performance-based shares and 30 thousand restricted stock shares that are non-vested at March 31, 2015 which will be settled in cash due to foreign regulatory limitations. The liability related to these grants reflects the current estimate of performance that will be achieved and the current common stock price.
As of March 31, 2015, based on current estimates of future performance, $48 million of unrecognized compensation cost related to performance-based awards is expected to be recognized through the first quarter of 2018 and $20 million of unrecognized compensation cost related to the restricted stock awards is expected to be recognized primarily through the first quarter of 2018.
10. Retirement Programs
The components of net pension and postretirement benefits other than pensions (“OPEB”) costs for the quarters ended March 31, 2015 and 2014 are shown below:
 
 
Quarter Ended March 31,
 
Pensions
 
OPEB
(Millions of dollars)
2015
 
2014
 
2015
 
2014
Service cost
$
14

 
$
13

 
$
1

 
$
1

Interest cost
28

 
31

 
2

 
3

Expected return on plan assets
(39
)
 
(40
)
 

 

Net amortization and deferral
20

 
15

 
(1
)
 
(2
)
Net periodic benefit cost before pension settlement charge
$
23

 
$
19

 
$
2

 
$
2

Praxair estimates that 2015 required contributions to its pension plans will be in the area of $15 million, of which $11 million have been made through March 31, 2015.

In 2014 a number of senior managers retired. These retirees are covered by the U.S. supplemental pension plan which provides for a lump sum benefit payment option. Under certain circumstances, such lump sum payments must be accounted for as a settlement of the related pension obligation, but only when paid. As a result, Praxair anticipates that it will record a pension settlement expense of approximately $7 million in the third quarter 2015 when the payments are made to the retirees.



17


11. Commitments and Contingencies
Contingent Liabilities
Praxair is subject to various lawsuits and government investigations that arise from time to time in the ordinary course of business. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Praxair has strong defenses in these cases and intends to defend itself vigorously. It is possible that the company may incur losses in connection with some of these actions in excess of accrued liabilities. Management does not anticipate that in the aggregate such losses would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a significant impact on the company’s reported results of operations in any given period (see Note 17 to the consolidated financial statements of Praxair’s 2014 Annual Report on Form 10-K).
Significant matters are:
During May 2009, the Brazilian government published Law 11941/2009 instituting a new voluntary amnesty program (“Refis Program”) which allowed Brazilian companies to settle certain federal tax disputes at reduced amounts. During the 2009 third quarter, Praxair decided that it was economically beneficial to settle many of its outstanding federal tax disputes and such disputes were enrolled in the Refis Program, subject to final calculation and review by the Brazilian federal government. The Company recorded estimated liabilities based on the terms of the Refis Program. Since 2009, Praxair has been unable to reach final agreement on the calculations and recently initiated litigation against the government in an attempt to resolve certain items. Open issues relate to the following matters: (i) application of cash deposits and net operating loss carryforwards to satisfy obligations, (ii) the amount of tax reductions available under the Refis Program, and (iii) income tax deductibility of payments. Although it is difficult to estimate the timing of resolution of legal matters in Brazil, it is possible that individual disputed matters may be resolved during the next year.
At March 31, 2015 the most significant non-income and income tax claims in Brazil, after enrollment in the Refis Program, relate to state VAT tax matters and a federal income tax matter where the taxing authorities are challenging the tax rate that should be applied to income generated by a subsidiary company. The total estimated exposure relating to such claims, including interest and penalties, as appropriate, is approximately $185 million. Praxair has not recorded any liabilities related to such claims based on management judgments, after considering judgments and opinions of outside counsel. Because litigation in Brazil historically takes many years to resolve, it is very difficult to estimate the timing of resolution of these matters; however, it is possible that certain of these matters may be resolved within the near term. The company is vigorously defending against the proceedings.
On September 1, 2010, CADE (Brazilian Administrative Council for Economic Defense) announced alleged anticompetitive activity on the part of five industrial gas companies in Brazil and imposed fines on all five companies. Originally, CADE imposed a civil fine of R$2.2 billion Brazilian reais (US$686 million) against White Martins, the Brazil-based subsidiary of Praxair, Inc. In response to a motion for clarification, the fine was reduced to R$1.7 billion Brazilian reais (US$530 million) due to a calculation error made by CADE. The amount of the fine is subject to indexation using SELIC. On September 2, 2010, Praxair issued a press release and filed a report on Form 8-K rejecting all claims and stating that the fine represents a gross and arbitrary disregard of Brazilian law.
On October 19, 2010, White Martins filed an annulment petition (“appeal”) with the Federal Court in Brasilia seeking to have the fine against White Martins entirely overturned. In order to suspend payment of the fine pending the completion of the appeal process, Brazilian law required that the company tender a form of guarantee in the amount of the fine as security. Currently, 50% of the guarantee is satisfied by letters of credit with a financial institution and 50% of the guarantee is satisfied by equity of a Brazilian subsidiary.
Praxair strongly believes that the allegations are without merit and that the fine will be entirely overturned during the appeal process. The company further believes that it has strong defenses and will vigorously defend against the allegations and related fine up to such levels of the Federal Courts in Brazil as may be necessary. Because appeals in Brazil historically take many years to resolve, it is very difficult to estimate when the appeal will be finally decided. Based on management judgments, after considering judgments and opinions of outside counsel, no reserve has been recorded for this proceeding as management does not believe that a loss is probable.

18


12. Segments
Sales and operating profit by segment for the quarters ended March 31, 2015 and 2014 are shown below. For a description of Praxair’s operating segments, refer to Note 18 to the consolidated financial statements of Praxair’s 2014 Annual Report on Form 10-K.
  
Quarter Ended March 31,
(Millions of dollars)
2015
 
2014
SALES(a) 
 
 
 
North America
$
1,499

 
$
1,580

Europe
326

 
397

South America
401

 
488

Asia
371

 
392

Surface Technologies
160

 
169

Total sales
$
2,757

 
$
3,026

  
Quarter Ended March 31,
(Millions of dollars)
2015
 
2014
OPERATING PROFIT
 
 
 
North America
$
379

 
$
378

Europe
62

 
79

South America
85

 
113

Asia
69

 
75

Surface Technologies
28

 
30

Total operating profit
$
623

 
$
675

 
(a)
Sales reflect external sales only. Intersegment sales, primarily from North America to other segments, were not material.


19



13. Equity and Redeemable Noncontrolling Interests
Equity
A summary of the changes in total equity for the quarters ended March 31, 2015 and 2014 is provided below:

Quarter Ended March 31,
(Millions of dollars)
2015
 
2014
Activity
Praxair, Inc.
Shareholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
 
Praxair, Inc.
Shareholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
Balance, beginning of period
$
5,623

 
$
387

 
$
6,010

 
$
6,609

 
$
394

 
$
7,003

Net income (a)
416

 
9

 
425

 
448

 
10

 
458

Other comprehensive income (loss)
(630
)
 
(21
)
 
(651
)
 
(17
)
 
(3
)
 
(20
)
Noncontrolling interests:
 
 
 
 
 
 
 
 
 
 
 
Additions (reductions) (b)

 
2

 
2

 
(24
)
 

 
(24
)
Dividends and other capital changes

 
(2
)
 
(2
)
 

 
(3
)
 
(3
)
Redemption value adjustments
(3
)
 

 
(3
)
 
(1
)
 

 
(1
)
Dividends to Praxair, Inc. common stock holders ($0.715 per share in 2015 and $0.65 per share in 2014)
(207
)
 

 
(207
)
 
(191
)
 

 
(191
)
Issuances of common stock:
 
 
 
 
 
 
 
 
 
 
 
For the dividend reinvestment and stock purchase plan
2

 

 
2

 
1

 

 
1

For employee savings and incentive plans
30

 

 
30

 
33

 

 
33

Purchases of common stock
(234
)
 

 
(234
)
 
(293
)
 

 
(293
)
Tax benefit from share-based compensation
14

 

 
14

 
20

 

 
20

Share-based compensation
7

 

 
7

 
15

 

 
15

Balance, end of period
$
5,018

 
$
375

 
$
5,393

 
$
6,600

 
$
398

 
$
6,998

 
 
 
 
 
 
 
 
 
 
 
 

(a)
Net income for noncontrolling interests excludes Net income related to redeemable noncontrolling interests of $3 million for the quarter ended March 31, 2015 ( $4 million for the same time periods in 2014, respectively), which is not part of total equity (see redeemable noncontrolling interests section below).
(b)
Praxair increased its ownership in certain consolidated subsidiaries. The difference between the purchase price and the related noncontrolling interests was recorded as a decrease in Praxair's additional paid-in-capital.
The components of AOCI are as follows:
 
March 31,
 
December 31,
(Millions of dollars)
2015
 
2014
Cumulative translation adjustment (includes $98 million and $64 million tax charge in March 31, 2015 and December 31, 2014, respectively)
 
 
 
North America
$
(655
)
 
$
(553
)
South America
(1,882
)
 
(1,510
)
Europe
(484
)
 
(432
)
Asia
(146
)
 
(49
)
Surface Technologies
(32
)
 
(7
)
 
(3,199
)
 
(2,551
)
Derivatives - net of taxes
(1
)
 
(1
)
Pension / OPEB funded status obligation (net of $332 million and $342 million tax benefit in March 31, 2015 and December 31, 2014, respectively)
(615
)
 
(633
)
 
$
(3,815
)
 
$
(3,185
)

20


Redeemable Noncontrolling Interests
Noncontrolling interests with redemption features, such as put/sell options, that are not solely within the Company’s control (“redeemable noncontrolling interests”) are reported separately in the consolidated balance sheets at the greater of carrying value or redemption value. For redeemable noncontrolling interests that are not yet exercisable, Praxair calculates the redemption value by accreting the carrying value to the redemption value over the period until exercisable. If the redemption value is greater than the carrying value, any increase is adjusted directly to equity and does not impact net income.
Redeemable noncontrolling interests include Yara Praxair, a joint venture in Scandinavia, and two packaged gas distributors in the United States where the noncontrolling interests have put options. In Scandinavia, the noncontrolling shareholder has the right to sell its shares to Praxair starting in 2015 for a period of 4 years at a formula price. Praxair also obtained the right to purchase the shares held by the noncontrolling shareholder starting in 2017 for a period of 2 years, also at a formula price.
The following is a summary of the changes in redeemable noncontrolling interests for the three months ended March 31, 2015 and 2014: 
(Millions of dollars)
2015
 
2014
Balance, January 1,
$
176

 
$
307

Net income
3

 
4

Distributions to noncontrolling interest
(3
)
 
(6
)
Redemption value adjustments/accretion
3

 
1

Foreign currency translation and other
(9
)
 
1

Purchase of noncontrolling interest *

 
(112
)
Balance, March 31,
$
170

 
$
195


* In January 2014, Praxair acquired the redeemable noncontrolling interests related to Praxair Distribution Mid-Atlantic, LLC. The cash payment is shown in the financing section of the condensed consolidated statements of cash flows under the caption "Noncontrolling interest transactions and other".

21


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Consolidated Results

Praxair's results in the first quarter were challenged by significant negative impacts from foreign currency translation, as the U.S. dollar strengthened sharply against most major foreign currencies. Praxair reported sales of $2,757 million, 9% below the prior-year quarter. Foreign currency translation reduced sales by 8% and lower cost pass-through, primarily natural gas, lowered sales by 2% compared to the first quarter of 2014. Excluding these impacts, organic sales were 1% above the prior year due to higher overall pricing levels. Overall volumes were comparable to the 2014 first quarter, as volume growth in North America and Asia was offset by lower volumes in South America. Operating profit decreased $52 million, or 8%, for the quarter ended March 31, 2015 versus the respective 2014 period primarily due to the impact of foreign currency translation. Excluding the foreign currency effects, operating profit was comparable to the prior-year period. Operating margin was a strong 22.6%, 30 basis points above the prior year quarter. Earnings per share of $1.43 was 5% below the prior year due to lower net income, primarily due to foreign currency translation impacts, which were partially offset by a reduction in the number of diluted shares outstanding as a result of the company's net repurchases of common stock.
Outlook
Diluted earnings per share for the second quarter of 2015 are expected to be in the range of $1.40 to $1.48.
Diluted earnings per share for the full year of 2015 are expected to be in the range of $5.90 to $6.15.
For the full year of 2015, Praxair expects sales in the area of $11.4 to $11.7 billion. Full-year capital expenditures are expected to be about $1.6 billion.

The company’s core business is to build, own, and operate industrial gas plants in order to supply atmospheric and process gases to customers. As such, Praxair believes that its backlog is one indicator of future sales growth. At March 31, 2015, Praxair’s backlog of 21 large projects under construction was $2.1 billion. This represents the total estimated capital cost of large plants under construction. North America represents approximately half of the backlog while Asia represents approximately 25%. The remaining backlog resides in Europe and in South America. These plants will supply customers in the energy, chemical, manufacturing, electronics and metals markets.
Praxair provides quarterly updates on operating results, material trends that may affect financial performance, and financial earnings guidance via quarterly earnings releases and investor teleconferences. These updates are available on the company’s website, www.praxair.com, but are not incorporated herein.


22


The following table provides summary data for the quarter ended March 31, 2015 and 2014:
  
Quarter Ended March 31,
(Dollar amounts in millions, except per share data)
2015
 
2014
 
Variance
Reported Amounts
 
 
 
 
 
Sales
$
2,757

 
$
3,026

 
(9
)%
Cost of sales, exclusive of depreciation and amortization
$
1,530

 
$
1,726

 
(11
)%
Gross margin (a)
$
1,227

 
$
1,300

 
(6
)%
As a percent of sales
44.5
%
 
43.0
%
 
 
Selling, general and administrative
$
299

 
$
326

 
(8
)%
As a percent of sales
10.8
%
 
10.8
%
 
 
Depreciation and amortization
$
277

 
$
285

 
(3
)%
Other income (expense) - net
$
(4
)
 
$
9

 
 
Operating profit
$
623

 
$
675

 
(8
)%
As a percent of sales
22.6
%
 
22.3
%
 
 
Interest expense - net
$
44

 
$
46

 
(4
)%
Effective tax rate
28.0
%
 
28.0
%
 
 
Income from equity investments
$
11

 
$
9

 
22
 %
Noncontrolling interests
$
(12
)
 
$
(14
)
 
(14
)%
Net income - Praxair, Inc.
$
416

 
$
448

 
(7
)%
Diluted earnings per share
$
1.43

 
$
1.51

 
(5
)%
Diluted shares outstanding
291,652

 
297,253

 
(2
)%
 
(a)
Gross margin excludes depreciation and amortization expense.


23


Results of Operations
The changes in consolidated sales and operating profit compared to the prior year are attributable to the following:
 
 
Quarter Ended March 31, 2015 vs. 2014
 
% Change
 
Sales
 
Operating Profit
Factors Contributing to Changes
 
 
 
Volume
 %
 
(3
)%
Price
1
 %
 
5
 %
Cost pass-through
(2
)%
 
 %
Currency
(8
)%
 
(8
)%
Acquisitions/divestitures
 %
 
 %
Other
 %
 
(2
)%
Reported
(9
)%
 
(8
)%
The following tables provide sales by end-market and distribution method:
 
 
Quarter Ended March 31,
 
% of Sales
 
% Change*
 
2015
 
2014
 
Sales by End Markets
 
 
 
 
 
Manufacturing
25
%
 
23
%
 
1
 %
Metals
17
%
 
17
%
 
(2
)%
Energy
13
%
 
13
%
 
3
 %
Chemicals
10
%
 
11
%
 
(7
)%
Electronics
7
%
 
7
%
 
5
 %
Healthcare
8
%
 
8
%
 
4
 %
Food & Beverage
8
%
 
8
%
 
7
 %
Aerospace
3
%
 
3
%
 
4
 %
Other
9
%
 
10
%
 
(9
)%
 
100
%
 
100
%
 
 
 * Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
 
 
Quarter Ended March 31,
 
% of Sales
 
2015
 
2014
Sales by Distribution Method
 
 
 
On- Site
28
%
 
30
%
Merchant
34
%
 
33
%
Packaged Gas
29
%
 
28
%
Other
9
%
 
9
%
 
100
%
 
100
%


Sales decreased $269 million, or 9%, for the three months ended March 31, 2015 versus 2014 period primarily due to negative currency translation impacts of 8%. Excluding negative currency effects and lower cost pass-through which reduced sales by 2%, sales increased 1% due to higher pricing.

Gross margin decreased $73 million, or 6%, for the three months ended March 31, 2015 versus the respective 2014 period primarily due to lower sales. Gross margin as percentage of sales improved to 44.5% for the three months ended March 31, 2015 from 43.0% for the three months ended March 31, 2014 primarily due to higher pricing.

24



Selling, general and administrative expenses ("SGA") decreased $27 million, or 8%, for the three months ended March 31, 2015 versus 2014 period primarily due to currency effects. SGA as a percent of sales was consistent with the prior-year quarter.

Depreciation and amortization expense decreased $8 million, or 3%, for the three months ended March 31, 2015 versus the respective 2014 period. Currency effects reduced depreciation and amortization expense by $21 million. This was partially offset by higher depreciation expense primarily related to new project start-ups.

Other income (expense) – net was $(4) million expense for the three months ended March 31, 2015, compared to $9 million of income in the prior-year quarter. Other income (expense) - net in 2014 included a gain on an asset sale in South America.

Operating profit decreased $52 million, or 8% in the quarter. Higher pricing increased operating profit by 5% which was more than offset by the negative impact of foreign currency translation. A discussion of operating profit by segment is included in the segment discussion that follows. Operating Margin improved 30 basis points from the prior-year quarter to 22.6%.

Interest expense-net decreased $2 million, or 4%, for the three months ended March 31, 2015 versus the respective 2014 period. Lower average interest rates reduced interest expense by $5 million. This decrease was partially offset by the impact of higher debt levels which increased interest expense by $3 million.

The effective tax rate was 28% for both periods presented.

Income from equity investments for the three months ended March 31, 2015 and 2014 was $11 million and $9 million, respectively. Praxair’s significant sources of equity income are in China, Italy, and the Middle East.

At March 31, 2015, non-controlling interests consisted primarily of non-controlling shareholders' investments in Asia (primarily China and India), Europe (primarily Italy and Scandinavia), and North America (primarily within the U.S. packaged gas business). Non-controlling interests decreased $2 million for the three months ended March 31, 2015 versus the respective 2014 period due primarily to the acquisition of the non-controlling interest in a U.S. packaged gas business during the first quarter of 2014, and impacts of foreign currency translation.

Net income-Praxair, Inc. decreased $32 million, or 7%, for three months ended March 31, 2015, versus the respective 2014 period primarily due to lower operating profit which was significantly impacted by foreign currency translation, partially offset by lower income tax and interest expense. Net income decreased less than sales due to lower costs including SGA expense, lower non-controlling interest and lower interest expense.

Earnings per share of $1.43 for the three months ended March 31, 2015 decreased 5% from the prior-year. This decrease is attributable to lower net income which was partially offset by a reduction in the number of diluted shares outstanding as a result of the company's net repurchases of common stock.

Other Comprehensive Income

Other comprehensive loss for the three months ended March 31, 2015 of $660 million results primarily from negative currency translation adjustments of $678 million. The translation adjustments reflect the impact of translating local currency foreign subsidiary financial statements to U.S. dollars. The negative translation adjustments in the quarter resulted primarily from the strengthening of the U.S. dollar against most major currencies. See "Currency" section of the MD&A for exchange rates used for translation purposes and Note 13 to the condensed consolidated financial statements for a summary of the currency translation adjustment component of accumulated other comprehensive income by segment.




25


Segment Discussion
The following summary of sales and operating profit by segment provides a basis for the discussion that follows.
 
 
Quarter Ended March 31,
(Dollar amounts in millions)
2015
 
2014
 
Variance
SALES
 
 
 
 
 
North America
$
1,499

 
$
1,580

 
(5
)%
Europe
326

 
397

 
(18
)%
South America
401

 
488

 
(18
)%
Asia
371

 
392

 
(5
)%
Surface Technologies
160

 
169

 
(5
)%
 
$
2,757

 
$
3,026

 
(9
)%
OPERATING PROFIT
 
 
 
 
 
North America
$
379

 
$
378

 
 %
Europe
62

 
79

 
(22
)%
South America
85

 
113

 
(25
)%
Asia
69

 
75

 
(8
)%
Surface Technologies
28

 
30

 
(7
)%
Segment operating profit
$
623

 
$
675

 
(8
)%


26


North America
 
Quarter Ended March 31,
 
2015
 
2014
 
Variance
Sales
$
1,499

 
$
1,580

 
(5
)%
Cost of sales, exclusive of depreciation and amortization
791

 
870

 
 
Gross margin
708

 
710

 
 
Operating expenses
179

 
183

 
 
Depreciation and amortization
150

 
149

 
 
Operating profit
$
379

 
$
378

 
 %
Margin %
25.3
%
 
23.9
%
 
 
 
 
Quarter Ended March 31, 2015 vs. 2014
 
% Change
 
Sales
 
Operating Profit
Factors Contributing to Changes
 
 
 
Volume
1
 %
 
2
 %
Price
 %
 
1
 %
Cost pass-through
(4
)%
 
 %
Currency
(3
)%
 
(3
)%
Acquisitions/divestitures
1
 %
 
1
 %
Other
 %
 
(1
)%
 
(5
)%
 
 %
The following tables provide sales by end-market and distribution method:
 
Quarter Ended March 31,
 
% of Sales
 
% Change*
 
2015
 
2014
 
Sales by End Markets
 
 
 
 
 
Manufacturing
31
%
 
30
%
 
1
 %
Metals
12
%
 
12
%
 
(8
)%
Energy
18
%
 
20
%
 
4
 %
Chemicals
10
%
 
11
%
 
(12
)%
Electronics
4
%
 
3
%
 
29
 %
Healthcare
7
%
 
7
%
 
5
 %
Food & Beverage
9
%
 
8
%
 
7
 %
Aerospace
1
%
 
1
%
 
(5
)%
Other
8
%
 
8
%
 
(4
)%
 
100
%
 
100
%
 
 
 * Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
 
Quarter Ended March 31,
 
% of Sales
 
2015
 
2014
Sales by Distribution Method
 
 
 
On- Site
28
%
 
32
%
Merchant
37
%
 
35
%
Packaged Gas
33
%
 
32
%
Other
2
%
 
1
%
 
100
%
 
100
%
The North America segment includes Praxair's industrial gases operations in the United States, Canada and Mexico.

27


North America segment sales decreased $81 million, or 5%, as compared to the prior-year quarter and decreased 2% excluding currency translation impacts. Organic sales growth was 1% driven primarily by higher volumes. By end-market, the increase in sales growth came primarily from manufacturing, food and beverage and healthcare, which was partially offset by a decline in the metals and chemicals end-markets. Acquisitions of packaged gas distributors added 1% growth during the current quarter. Lower cost pass-through, primarily relating to natural gas prices passed through to hydrogen customers, decreased sales by 4%. On-site sales were lower as a percent of total sales due to lower volumes of pipeline oxygen to steel customers, and lower hydrogen sales due to pass-through of lower natural gas prices. Overall on-site hydrogen volumes were above the prior-year quarter.
North America segment operating profit increased $1 million in the quarter as compared to the prior year. Excluding the effects of currency, operating profit increased 3% which was primarily driven by higher volumes and pricing and acquisitions.
Europe
 
Quarter Ended March 31,
 
2015
 
2014
 
Variance %
Sales
$
326

 
$
397

 
(18
)%
Cost of sales, exclusive of depreciation and amortization
182

 
218

 
 
Gross margin
144

 
179

 
 
Operating expenses
46

 
57

 
 
Depreciation and amortization
36

 
43

 
 
Operating profit
$
62

 
$
79

 
(22
)%
Margin %
19.0
%
 
19.9
%
 
 
 
Quarter Ended March 31, 2015 vs. 2014
 
% Change
 
% Change
 
Sales
 
Operating Profit
Factors Contributing to Changes
 
 
 
Volume
 %
 
(1
)%
Price
1
 %
 
2
 %
Cost pass-through
 %
 
 %
Currency
(18
)%
 
(19
)%
Acquisitions/divestitures
(1
)%
 
1
 %
Other
 %
 
(5
)%
 
(18
)%
 
(22
)%

The following tables provide sales by end-market and distribution method:
 
Quarter Ended March 31,
 
% of Sales
 
% Change*
 
2015
 
2014
 
Sales by End Markets
 
 
 
 
 
Manufacturing
22
%
 
23
%
 
1
 %
Metals
17
%
 
16
%
 
8
 %
Energy
6
%
 
6
%
 
(8
)%
Chemicals
14
%
 
16
%
 
(6
)%
Electronics
8
%
 
7
%
 
8
 %
Healthcare
11
%
 
11
%
 
(1
)%
Food & Beverage
9
%
 
9
%
 
2
 %
Aerospace
1
%
 
1
%
 
 %
Other
12
%
 
11
%
 
 %
 
100
%
 
100
%
 
 
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures

28


 
Quarter Ended March 31,
 
% of Sales
 
2015
 
2014
Sales by Distribution Method
 
 
 
On- Site
19
%
 
19
%
Merchant
34
%
 
35
%
Packaged Gas
43
%
 
43
%
Other
4
%
 
3
%
 
100
%
 
100
%
Europe segment sales decreased by $71 million or 18% in the first quarter as compared to the prior year due to negative currency translation impacts. Excluding currency, overall sales were comparable to the prior-year quarter. Higher pricing increased sales by 1%; this was offset by the divestiture in 2014 of an industrial gases business in France. By end-market, sales increased to metals, food and beverage and partially offset by lower sales to energy customers.
Europe segment operating profit decreased by $17 million, or 22% in the first quarter as compared to the prior year. The decrease was primarily due to currency impacts and higher costs, as costs in the prior-year quarter were reduced by $5 million of energy credits in Italy.
South America
 
Quarter Ended March 31,
 
2015
 
2014
 
Variance
Sales
$
401

 
$
488

 
(18
)%
Cost of sales, exclusive of depreciation and amortization
221

 
276

 
 
Gross margin
180

 
212

 
 
Operating expenses
57

 
56

 
 
Depreciation and amortization
38

 
43

 
 
Operating profit
$
85

 
$
113

 
(25
)%
Margin %
21.2
%
 
23.2
%
 
 

 
Quarter Ended March 31, 2015 vs. 2014
 
% Change
 
% Change
 
Sales
 
Operating Profit
Factors Contributing to Changes
 
 
 
Volume
(5
)%
 
(16
)%
Price
6
 %
 
27
 %
Cost pass-through
1
 %
 
 %
Currency
(20
)%
 
(20
)%
Acquisitions/divestitures
 %
 
 %
Other
 %
 
(16
)%
 
(18
)%
 
(25
)%

29


The following tables provide sales by end-market and distribution method:
 
Quarter Ended March 31,
 
% of Sales
 
% Change*
 
2015
 
2014
 
Sales by End Markets
 
 
 
 
 
Manufacturing
22
%
 
21
%
 
5
 %
Metals
28
%
 
29
%
 
(4
)%
Energy
2
%
 
2
%
 
 %
Chemicals
9
%
 
9
%
 
3
 %
Electronics
%
 
%
 
 %
Healthcare
17
%
 
16
%
 
7
 %
Food & Beverage
13
%
 
13
%
 
7
 %
Aerospace
%
 
%
 
 %
Other
9
%
 
10
%
 
(9
)%
 
100
%
 
100
%
 
 
 * - Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
 
Quarter Ended March 31,
 
% of Sales
 
2015
 
2014
Sales by Distribution Method
 
 
 
On- Site
27
%
 
27
%
Merchant
41
%
 
42
%
Packaged Gas
30
%
 
28
%
Other
2
%
 
3
%
 
100
%
 
100
%
South America segment sales in the first quarter decreased $87 million or 18% versus the prior-year quarter. Currency translation impacts reduced sales by 20%, primarily due to the strengthening of the U.S. dollar versus the Brazilian Real. Excluding negative currency impacts, sales grew 2% primarily from higher pricing. This was partially offset by lower volumes to on-site, merchant and packaged gases customers in Brazil and across the region due to a decline in economic activity associated with lower industrial production. Lower sales primarily to metals customers was partially offset by growth in healthcare and food and beverage markets.
Segment operating profit decreased $28 million, or 25%, in the first quarter, primarily due to negative currency effects, lower volumes, and higher costs due to inflation. These decreases were partially offset by higher pricing. Operating profit in the prior-year quarter included a gain on an asset sale in Brazil which increased operating profit by 6%.

Asia
 
Quarter Ended March 31,
 
2015
 
2014
 
Variance
Sales
$
371

 
$
392

 
(5
)%
Cost of sales, exclusive of depreciation and amortization
233

 
251

 
 
Gross margin
138

 
141

 
 
Operating expenses
26

 
27

 
 
Depreciation and amortization
43

 
39

 
 
Operating profit
$
69

 
$
75

 
(8
)%
Margin %
18.6
%
 
19.1
%
 
 
 

30


 
Quarter Ended March 31, 2015 vs. 2014
 
% Change
 
% Change
 
Sales
 
Operating Profit
Factors Contributing to Changes
 
 
 
Volume / Sale of Equipment
(2
)%
 
(11
)%
Price
 %
 
(2
)%
Cost pass-through
(2
)%
 
 %
Currency
(2
)%
 
(2
)%
Acquisitions/divestitures
1
 %
 
1
 %
Other
 %
 
6
 %
 
(5
)%
 
(8
)%
The following tables provide sales by end-market and distribution method:
 
Quarter Ended March 31,
 
% of Sales
 
% Change*

 
2015
 
2014
 
Sales by End Markets
 
 
 
 
 
Manufacturing
10
%
 
10
%
 
(7
)%
Metals
30
%
 
27
%
 
9
 %
Energy
3
%
 
2
%
 
5
 %
Chemicals
12
%
 
12
%
 
(2
)%
Electronics
32
%
 
32
%
 
(6
)%
Healthcare
1
%
 
1
%
 
 %
Food & Beverage
2
%
 
2
%
 
 %
Aerospace
%
 
%
 
 %
Other
10
%
 
14
%
 
(30
)%
 
100
%
 
100
%
 
 
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures
 
 
Quarter Ended March 31,
 
% of Sales
 
2015
 
2014
Sales by Distribution Method
 
 
 
On- Site
50
%
 
51
%
Merchant
31
%
 
28
%
Packaged Gas
12
%
 
12
%
Other
7
%
 
9
%
 
100
%
 
100
%
Asia segment sales decreased $21 million, or 5%, in the first quarter as compared to the prior year. A 2% decline in volumes was primarily due to a plant sale in China in the prior-year quarter. New project start-ups in India, Korea and China contributed organic volume growth. Cost pass-through related to the contractual pass-through of precious metals prices used in electronic materials reduced sales by 2%, with minimal impact on operating profit. By end-market, sales grew primarily to metals customers in India, offset by lower sales to manufacturing and electronic materials markets.
Asia segment operating profit decreased $6 million, or 8% in the first quarter as compared to the prior year. Lower volumes, largely due to the prior-quarter sale of equipment and lower pricing in China reduced operating profit by 13%. This was partially offset by lower costs and productivity gains.

31


Surface Technologies
 
Quarter Ended March 31,
 
2015
 
2014
 
Variance
Sales
$
160

 
$
169

 
(5
)%
Cost of sales, exclusive of depreciation and amortization
103

 
111

 
 
Gross margin
57

 
58

 
 
Operating expenses
19

 
17

 
 
Depreciation and amortization
10

 
11

 
 
Operating profit
$
28

 
$
30

 
(7
)%
Margin %
17.5
%
 
17.8
%
 
 
 
 
Quarter Ended March 31, 2015 vs. 2014
 
% Change
 
% Change
 
Sales
 
Operating Profit
Factors Contributing to Changes
 
 
 
Volume/Price
2
 %
 
4
 %
Cost pass-through
 %
 
 %
Currency
(7
)%
 
(9
)%
Acquisitions/divestitures
 %
 
(1
)%
Other
 %
 
(1
)%
 
(5
)%
 
(7
)%


The following table provides sales by end-market:
 
Quarter Ended March 31,
 
% of Sales
 
% Change*
 
2015
 
2014
 
Sales by End Markets
 
 
 
 
 
Manufacturing
12
%
 
13
%
 
(4
)%
Metals
7
%
 
8
%
 
(10
)%
Energy
26
%
 
27
%
 
(2
)%
Chemicals
2
%
 
2
%
 
 %
Electronics
1
%
 
1
%
 
 %
Healthcare
%
 
%
 
 %
Food & Beverage
3
%
 
3
%
 
 %
Aerospace
36
%
 
33
%
 
8
 %
Other
13
%
 
13
%
 
(5
)%
 
100
%
 
100
%
 
 
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures
Surface Technologies segment sales decreased $9 million, or 5% in the first quarter as compared to the prior year. Currency impacts reduced sales by 7% primarily due to a weaker Euro, Japanese yen and British pound versus the U.S. dollar. This decrease was partially offset by 2% growth in organic sales, primarily due to higher coatings sales to the aerospace end-market.

Surface Technologies segment operating profit decreased $2 million, or 7% in the first quarter. Excluding currency, operating profit grew 3% from organic sales growth and cost control.

32


Currency
The results of Praxair’s non-U.S. operations are translated to the company’s reporting currency, the U.S. dollar, from the functional currencies. For most foreign operations, Praxair uses the local currency as its functional currency. There is inherent variability and unpredictability in the relationship of these functional currencies to the U.S. dollar and such currency movements may materially impact Praxair’s results of operations in any given period.
To help understand the reported results, the following is a summary of the significant currencies underlying Praxair’s consolidated results and the exchange rates used to translate the financial statements (rates of exchange expressed in units of local currency per U.S. dollar):
 
 
Percentage of YTD 2015 Consolidated Sales
 
Exchange Rate for
Income Statement
 
Exchange Rate for
Balance Sheet
 
Year-To-Date Average
 
March 31,
 
December 31,
Currency
2015
 
2014
 
2015
 
2014
Brazilian real
12
%
 
2.85

 
2.36

 
3.21

 
2.66

Euro
12
%
 
0.89

 
0.73

 
0.93

 
0.83

Canadian dollar
7
%
 
1.24

 
1.10

 
1.27

 
1.16

Mexican peso
6
%
 
14.95

 
13.24

 
15.26

 
14.75

Chinese yuan
5
%
 
6.24

 
6.10

 
6.20

 
6.21

Korean won
4
%
 
1,100

 
1,070

 
1,110

 
1,094

India rupee
3
%
 
62.26

 
61.79

 
62.50

 
63.04

Argentine peso
1
%
 
8.69

 
7.60

 
8.82

 
8.55

Norwegian krone
<1%

 
7.75

 
6.09

 
8.05

 
7.45

Colombian peso
<1%

 
2,467

 
2,005

 
2,598

 
2,392

Russian ruble
<1%

 
62.80

 
35.06

 
58.19

 
60.74

Thailand bhat
<1%

 
32.65

 
32.65

 
32.54

 
32.91

 





33



Liquidity, Capital Resources and Other Financial Data
The following selected cash flow information provides a basis for the discussion that follows:
(Millions of dollars)
Three Months Ended March 31,
 
2015
 
2014
NET CASH PROVIDED BY (USED FOR):
 
 
 
OPERATING ACTIVITIES
 
 
 
Net income (including noncontrolling interest)
$
428

 
$
462

Non-cash charges (credits):
 
 
 
Add: Depreciation and amortization
277

 
285

Add: Deferred income taxes
14

 
23

Add: Share-based compensation
7

 
15

Net income adjusted for non-cash charges
726

 
785

Working capital
(120
)
 
(248
)
Pension contributions
(11
)
 
(9
)
Long-term assets, liabilities and other
(87
)
 
8

Net cash provided by operating activities
$
508

 
$
536

INVESTING ACTIVITIES
 
 
 
Capital expenditures
(397
)
 
(393
)
Acquisitions, net of cash acquired
(5
)
 
(124
)
Divestitures and asset sales
2

 
66

Net cash used for investing activities
$
(400
)
 
$
(451
)
FINANCING ACTIVITIES
 
 
 
Debt increases (reductions) - net
290

 
464

Issuances (purchases) of common stock - net
(191
)
 
(237
)
Cash dividends - Praxair, Inc. shareholders
(207
)
 
(191
)
Excess tax benefit on share-based compensation
14

 
20

Noncontrolling interest transactions and other
(6
)
 
(140
)
Net cash (used for) provided by financing activities
$
(100
)
 
$
(84
)
 
 
 
 
Effect of exchange rate changes on cash and cash equivalents
$
(17
)
 
$
5

Cash and cash equivalents, end-of-period
$
117

 
$
144

 
Cash Flow from Operations
Cash provided by operations of $508 million for the three months ended March 31, 2015 decreased $28 million, or 5%, versus 2014. The decrease was primarily due to lower net income adjusted for non-cash charges and changes in long-term assets, liabilities and other, partially offset by lower working capital requirements as compared to the prior year.
Praxair estimates that total 2015 required contributions to its pension plans will be in the area of $15 million, of which $11 million have been made through March 31, 2015. At a minimum, Praxair contributes to its pension plans to comply with local regulatory requirements (e.g., ERISA in the United States). Discretionary contributions in excess of the local minimum requirements are made based on many factors, including long-term projections of the plans' funded status, the economic environment, potential risk of overfunding, pension insurance costs and alternative uses of the cash. Changes to these factors can impact the amount and timing of discretionary contributions from year to year.
Investing
Net cash used for investing of $400 million for the three months ended March 31, 2015 decreased $51 million versus 2014 primarily due to lower acquisition expenditures, and lower proceeds from divestitures and asset sales.

34


Capital expenditures for the three months ended March 31, 2015 were $397 million, $4 million above the prior year. Capital expenditures in the quarter related primarily to investments in new plant and production equipment for growth. Approximately 60% of the capital expenditures were in North America with the rest in Asia, Europe and South America.
Acquisitions in the quarter were $5 million primarily relating to the acquisition of a packaged gases business in South America. Acquisitions in the prior-year period of $124 million were primarily the acquisition of an industrial gases business in Italy and packaged gas businesses in North and South America, and an equity investment in the Middle East. (see Note 2 to the condensed consolidated financial statements).
For the three months ended March 31, 2015 divestitures and asset sales were $2 million. Divestitures in the prior-year period were $66 million, primarily the sale of Praxair's industrial gas business in France.
Financing
Cash used for financing activities was $100 million for the three-month period ended March 31, 2015. Cash dividends were $207 million, higher than the prior year due to a 10% increase in dividends per share from $0.65 to $0.715. Net repurchases of common stock were $191 million and debt increased by $290 million.
In February 2015, Praxair issued $150 million of floating rate notes that bear interest at the Federal funds effective rate plus 0.33% due 2017, $400 million of 2.65% fixed rate notes due 2025 and $200 million of 3.550% fixed rate notes due in 2042.
In March 2015, Praxair repaid $500 million of 4.625% notes that became due.

Debt Covenants
Praxair’s $2.5 billion senior unsecured credit facility and long-term debt agreements contain various covenants (refer to Note 11 to the consolidated financial statements of Praxair’s 2014 Annual Report on Form 10-K). The only financial covenant requires Praxair not to exceed a maximum 70% leverage ratio, as defined in the agreements. For purposes of the leverage ratio calculation, consolidated shareholders' equity excludes changes in the cumulative foreign currency translation adjustments after June 30, 2011. At both March 31, 2015 and December 31, 2014, the actual leverage ratio calculated in accordance with the agreements was 54%.

Other Financial Data

Praxair's debt to capital ratio was 62.5% at March 31, 2015 versus 55.9% at March 31, 2014. Although net debt increased $153 million, the increase is due primarily to lower capital. The equity component of capital was reduced by a $1,817 million loss in accumulated other comprehensive income, primarily from currency impacts.

After-tax return on capital ("ROC") was consistent year-over-year at 12.6% for the four-quarter trailing period ended March 31, 2015 and 2014.

Return on equity ("ROE") for the four-quarter trailing period ended March 31, 2015 was strong at 29.6% and 90 basis-points above prior year.

EBITDA of $911 million for the 2015 quarter decreased $58 million from $969 million in 2014 due primarily to negative currency translation impacts.

Debt-to-Adjusted EBITDA was consistent year-over-year at 2.3 for the four-quarter trailing period ended March 31, 2015 and 2014.
 
See the "Non-GAAP Financial Measures" section below for definitions and reconciliations of these non-GAAP measures to reported GAAP amounts.
Legal Proceedings
See Note 11 to the condensed consolidated financial statements.



35


Non-GAAP Financial Measures
The following non-GAAP measures are intended to supplement investors’ understanding of the company’s financial information by providing measures which investors, financial analysts and management use to help evaluate the company’s financial leverage, return on net assets employed and operating performance. Special items which the company does not believe to be indicative of on-going business trends are excluded from these calculations so that investors can better evaluate and analyze historical and future business trends on a consistent basis. Definitions of these non-GAAP measures may not be comparable to similar definitions used by other companies and are not a substitute for similar GAAP measures.
The following are the non-GAAP measures presented in the MD&A:
 
 
March 31,
(Dollar amounts in millions, except per share data)
2015
 
2014
Debt-to-capital
62.5
%
 
55.9
%
After-tax return on capital
12.6
%
 
12.6
%
Return on equity
29.6
%
 
28.7
%
EBITDA
$
911

 
$
969

Debt-to-adjusted EBITDA
2.3

 
2.3


Debt-to-Capital Ratio
The debt-to-capital ratio is a measure used by investors, financial analysts and management to provide a measure of financial leverage and insights into how the company is financing its operations.
 
Three Months Ended March 31,
 
2015
 
2014
(Dollar amounts in millions)
 
 
 
Debt
$
9,396

 
$
9,270

Less: cash and cash equivalents
(117
)
 
(144
)
Net debt
9,279

 
9,126

Equity and redeemable noncontrolling interests
 
 
 
Redeemable noncontrolling interests
170

 
195

Praxair, Inc. shareholders’ equity
5,018

 
6,600

Noncontrolling interests
375

 
398

Total equity and redeemable noncontrolling interests
5,563


7,193

Capital
$
14,842

 
$
16,319

DEBT-TO-CAPITAL RATIO
62.5
%
 
55.9
%

36


After-tax Return on Capital (ROC)
After-tax return on capital is a measure used by investors, financial analysts and management to evaluate the return on net assets employed in the business. ROC measures the after-tax operating profit that the company was able to generate with the investments made by all parties in the business (debt, noncontrolling interests and Praxair, Inc. shareholders’ equity).
 
2015
 
2014
 
Four
Quarter
Trailing
 
Three Months Ended
 
Nine Months Ended
 
Four
Quarter
Trailing
 
Three Months Ended
 
Nine Months Ended
 
 
March 31, 2015
 
December 31, 2014
 
 
March 31, 2014
 
December 31, 2013
(Dollar amounts in millions)
 
 
 
 
 
 
 
 
 
 
 
Adjusted operating profit (see below)
$
2,694

 
$
623

 
$
2,071

 
$
2,709

 
$
675

 
$
2,034

Less: adjusted income taxes (see below)
(693
)
 
(162
)
 
(531
)
 
(710
)
 
(176
)
 
(534
)
Less: tax benefit on interest expense*
(49
)
 
(12
)
 
(37
)
 
(46
)
 
(13
)
 
(33
)
Add: equity income
44

 
11

 
33

 
37

 
9

 
28

Net operating profit after-tax (NOPAT)
$
1,996


$
460


$
1,536


$
1,990


$
495


$
1,495

Capital:
 
 
 
 
 
 
 
 
 
 
 
March 31st, 2015 & 2014
$
14,842

 
 
 
 
 
$
16,319

 
 
 
 
December 31st, 2014 & 2013
$
15,318

 
 
 
 
 
$
15,983

 
 
 
 
September 30th, 2014 & 2013
$
16,083

 
 
 
 
 
$
15,757

 
 
 
 
June 30th, 2014 & 2013
$
16,492

 
 
 
 
 
$
15,548

 
 
 
 
March 31st, 2014 & 2013
$
16,319

 
 
 
 
 
$
15,344

 
 
 
 
Five-quarter average
$
15,811

 
 
 
 
 
$
15,790

 
 
 
 
AFTER-TAX ROC
12.6
%
 
 
 
 
 
12.6
%
 
 
 
 

Tax benefit on interest expense is computed using the effective rate. The effective tax rate used was 28% for 2015 and 2014.

Return on Praxair, Inc. Shareholders’ Equity (ROE)
Return on Praxair, Inc. shareholders’ equity is a measure used by investors, financial analysts and management to evaluate operating performance from a Praxair shareholder perspective. ROE measures the net income attributable to Praxair, Inc. that the company was able to generate with the money shareholders have invested.
 
2015
 
2014
 
Four
Quarter
Trailing
 
Three Months Ended
 
Nine Months Ended
 
Four
Quarter
Trailing
 
Three Months Ended
 
Nine Months Ended
 
 
March 31, 2015
 
December 31, 2014
 
 
March 31, 2014
 
December 31, 2013
(Dollar amounts in millions)
 
 
 
 
 
 
 
 
 
 
 
Adjusted Net income - Praxair, Inc. (see below)
$
1,820

 
$
416

 
$
1,404

 
$
1,806

 
$
448

 
$
1,358

Praxair, Inc. shareholders’ equity
 
 
 
 
 
 
 
 
 
 
 
March 31st, 2015 & 2014
$
5,018

 
 
 
 
 
$
6,600

 
 
 
 
December 31st, 2014 & 2013
$
5,623

 
 
 
 
 
$
6,609

 
 
 
 
September 30th, 2014 & 2013
$
6,552

 
 
 
 
 
$
6,210

 
 
 
 
June 30th, 2014 & 2013
$
6,911

 
 
 
 
 
$
5,928

 
 
 
 
March 31st, 2014 & 2013
$
6,600

 
 
 
 
 
$
6,169

 
 
 
 
Five-quarter average
$
6,141

 
 
 
 
 
$
6,303

 
 
 
 
ROE
29.6
%
 
 
 
 
 
28.7
%
 
 
 
 

37


Adjusted EBITDA, Adjusted EBITDA Margin and Debt-to-Adjusted EBITDA Ratio
These measures are used by investors, financial analysts and management to assess a company’s ability to meet its financial obligations.
 
 
 
 
 
 
 
 
 
 
 
 
 
2015
 
2014
 
Four
Quarter
Trailing
 
Three Months Ended
 
Nine Months Ended
 
Four
Quarter
Trailing
 
Three Months Ended
 
Nine Months Ended
 
 
March 31, 2015
 
December 31, 2014
 
 
March 31, 2014
 
December 31, 2013
(Dollar amounts in millions)
 
 
 
 
 
 
 
 
 
 
 
Adjusted net income - Praxair, Inc. (see below)
$
1,820

 
$
416

 
$
1,404

 
$
1,806

 
$
448

 
$
1,358

Add: adjusted noncontrolling interest (see below)
50

 
12

 
38

 
64

 
14

 
50

Add: adjusted interest expense - net (see below)
175

 
44

 
131

 
166

 
46

 
120

Add: adjusted income taxes (see below)
693

 
162

 
531

 
710

 
176

 
534

Add: depreciation and amortization
1,162

 
277

 
885

 
1,128

 
285

 
843

ADJUSTED EBITDA
$
3,900

 
$
911

 
$
2,989

 
$
3,874

 
$
969

 
$
2,905

 
 
 
 
 
 
 
 
 
 
 
 
Reported Sales
 
 
2,757

 
 
 
 
 
3,026

 
 
Adjusted EBITDA Margin
 
 
33.0
%
 
 
 
 
 
32.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Debt:
 
 
 
 
 
 
 
 
 
 
 
March 31st, 2015 & 2014
$
9,279

 
 
 
 
 
$
9,126

 
 
 
 
December 31st, 2014 & 2013
$
9,132

 
 
 
 
 
$
8,673

 
 
 
 
September 30th, 2014 & 2013
$
8,953

 
 
 
 
 
$
8,892

 
 
 
 
June 30th, 2014 & 2013
$
8,992

 
 
 
 
 
$
9,004

 
 
 
 
March 31st, 2014 & 2013
$
9,126

 
 
 
 
 
$
8,563

 
 
 
 
Five-quarter average
$
9,096

 
 
 
 
 
$
8,852

 
 
 
 
DEBT-TO-ADJUSTED EBITDA RATIO
2.3

 
 
 
 
 
2.3

 
 
 
 

38


Adjusted Amounts
Adjusted amounts for the nine months ended December 31, 2014 exclude the impact of the Venezuela currency devaluation, pension settlement charge and bond redemption charge. Adjusted amounts for the nine months ended December 31, 2013 exclude the impact of pension settlement, bond redemption charge and income tax benefit. The company does not believe these items are indicative of on-going business trends and, accordingly, the impact is excluded from the reported amounts so that investors can better evaluate and analyze historical and future business trends on a consistent basis. For a description of these items, refer to Notes 2, 5 & 11 to the consolidated financial statements of Praxair’s 2014 Annual Report on Form 10-K.
Certain amounts for 2014 and 2013 have been included for reference purposes and to facilitate the calculations contained herein.
 
Quarter Ended March 31,
 
Nine Months Ended December 31,
 
(Dollar amounts in millions, except per share data)
2015
 
2014
 
2014
 
2013
 
Adjusted Operating Profit
 
 
 
 
 
 
 
 
Reported operating profit
$
623

 
$
675

 
$
1,933

 
$
2,025

 
Add: Venezuela currency devaluation

 

 
131

 

 
Add: Pension settlement charge

 

 
7

 
9

 
Total adjustments

 

 
138

 
9

 
Adjusted operating profit
$
623

 
$
675

 
$
2,071

 
$
2,034

 
Reported percent change
(8
)%
 
 
 
(5
)%
 
 
 
Adjusted percent change
(8
)%
 
 
 
2
 %
 
 
 
Adjusted Interest Expense
 
 
 
 
 
 
 
 
Reported interest expense
$
44

 
$
46

 
$
167

 
$
138

 
Less: Bond redemption

 

 
(36
)
 
(18
)
 
  Total adjustments

 

 
(36
)
 
(18
)
 
Adjusted interest expense
$
44

 
$
46

 
$
131

 
$
120

 
Adjusted Income Taxes and Effective Tax Rate
 
 
 
 
 
 
 
 
Reported income taxes
$
162

 
$
176

 
$
515

 
$
485

 
Add: Bond redemption

 

 
14

 
6

 
Add: Income tax benefit

 

 

 
40

 
Add: Pension settlement charge

 

 
2

 
3

 
Total adjustments

 

 
16

 
49

 
Adjusted income taxes
$
162

 
$
176

 
$
531

 
$
534

 

39


 
Quarter Ended March 31,
 
Nine Months Ended December 31,
 
(Dollar amounts in millions, except per share data)
2015
 
2014
 
2014
 
2013
 
Adjusted Effective Tax Rate
 
 
 
 
 
 
 
 
Reported income before income taxes and equity investments
$
579

 
$
629

 
$
1,766

 
$
1,887

 
Add: Bond redemption

 

 
36

 
18

 
Add: Pension settlement charge

 

 
7

 
9

 
Add: Venezuela currency devaluation

 

 
131

 

 
Total adjustments

 

 
174

 
27

 
Adjusted income before income taxes and equity investments
$
579

 
$
629

 
$
1,940

 
$
1,914

 
Adjusted effective tax rate
28.0
 %
 
28.0
%
 
27.4
 %
 
27.9
%
 
Adjusted Noncontrolling Interests
 
 
 
 
 
 
 
 
Reported noncontrolling interests
$
12

 
$
14

 
$
38

 
$
66

 
Less: Income tax benefit

 

 

 
(16
)
 
Total adjustments

 

 

 
(16
)
 
Adjusted Noncontrolling Interests
$
12

 
$
14

 
$
38

 
$
50

 
Adjusted Net Income - Praxair, Inc.
 
 
 
 
 
 
 
 
Reported net income - Praxair, Inc.
$
416

 
$
448

 
$
1,246

 
$
1,364

 
Add: Bond redemption

 

 
22

 
12

 
Less: Income tax benefit

 

 

 
(24
)
 
Add: Pension settlement charge

 

 
5

 
6

 
Add: Venezuela currency devaluation

 

 
131

 

 
Total adjustments

 

 
158

 
(6
)
 
Adjusted net income - Praxair, Inc.
$
416

 
$
448

 
$
1,404

 
$
1,358

 
Reported percent change
(7
)%
 
 
 
(9
)%
 
 
 
Adjusted percent change
(7
)%
 
 
 
3
 %
 
 
 

40


Percentage Change in Full - Year 2015 Diluted EPS Guidance
 
Low
End
 
High
End
2015 Diluted EPS guidance
$
5.90

 
$
6.15

2014 Adjusted Diluted EPS (see 2014 Annual Report on Form 10-K)
$
6.27

 
$
6.27

Percentage change from 2014 adjusted amounts
(6
)%
 
(2
)%
New Accounting Standards
Refer to Note 1 of the condensed consolidated financial statements.
Forward-looking Statements
This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s reasonable expectations and assumptions as of the date the statements are made but involve risks and uncertainties. These risks and uncertainties include, without limitation: the performance of stock markets generally; developments in worldwide and national economies and other international events and circumstances; changes in foreign currencies and in interest rates; the cost and availability of electric power, natural gas and other raw materials; the ability to achieve price increases to offset cost increases; catastrophic events including natural disasters, epidemics and acts of war and terrorism; the ability to attract, hire, and retain qualified personnel; the impact of changes in financial accounting standards; the impact of changes in pension plan liabilities; the impact of tax, environmental, healthcare and other legislation and government regulation in jurisdictions in which the company operates; the cost and outcomes of investigations, litigation and regulatory proceedings; continued timely development and market acceptance of new products and applications; the impact of competitive products and pricing; future financial and operating performance of major customers and industries served; the impact of information technology system failures, network disruptions and breaches in data security; and the effectiveness and speed of integrating new acquisitions into the business. These risks and uncertainties may cause actual future results or circumstances to differ materially from the projections or estimates contained in the forward-looking statements. The company assumes no obligation to update or provide revisions to any forward-looking statement in response to changing circumstances. The above listed risks and uncertainties are further described in Item 1A (Risk Factors) in this report which should be reviewed carefully. Please consider the company’s forward-looking statements in light of those risks.

41


Item 3. Quantitative and Qualitative Disclosures About Market Risk
Refer to Item 7A. to Part II of Praxair’s 2014 Annual Report on Form 10-K for discussion.
Item 4. Controls and Procedures
(a)
Based on an evaluation of the effectiveness of Praxair’s disclosure controls and procedures, which was made under the supervision and with the participation of management, including Praxair’s principal executive officer and principal financial officer, the principal executive officer and principal financial officer have each concluded that, as of the end of the quarterly period covered by this report, such disclosure controls and procedures are effective in ensuring that information required to be disclosed by Praxair in reports that it files under the Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and accumulated and communicated to management including Praxair’s principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.
(b)
There were no changes in Praxair’s internal control over financial reporting that occurred during the quarterly period covered by this report that have materially affected, or are reasonably likely to materially affect, Praxair’s internal control over financial reporting.

42


PART II - OTHER INFORMATION
Praxair, Inc. and Subsidiaries
 
Item 1. Legal Proceedings
See Note 11 to the condensed consolidated financial statements for a description of current legal proceedings.
Item 1A. Risk Factors
Due to the size and geographic reach of the company’s operations, a wide range of factors, many of which are outside of the company’s control, could materially affect the company’s future operations and financial performance. Management believes the following risks may significantly impact the company:
General Economic Conditions - Weakening economic conditions in markets in which the company does business may adversely impact the company’s financial results and/or cash flows.
Praxair serves a diverse group of industries across more than 50 countries, which generally leads to financial stability through various business cycles. However, a broad decline in general economic or business conditions in the industries served by its customers could adversely affect the demand for Praxair’s products and impair the ability of our customers to satisfy their obligations to the company, resulting in uncollected receivables and/or unanticipated contract terminations or project delays. In addition, many of the company’s customers are in businesses that are cyclical in nature, such as the chemicals, electronics, metals and refining industries. Downturns in these industries may adversely impact the company during these cycles. Additionally, such conditions could impact the utilization of the company’s manufacturing capacity which may require the company to recognize impairment losses on tangible assets such as property, plant and equipment as well as intangible assets such as intellectual property or goodwill.
Cost and Availability of Raw Materials and Energy - Increases in the cost of energy and raw materials and/or disruption in the supply of these materials could result in lost sales or reduced profitability.
Energy is the single largest cost item in the production and distribution of industrial gases. Most of Praxair’s energy requirements are in the form of electricity, natural gas and diesel fuel for distribution. Praxair attempts to minimize the financial impact of variability in these costs through the management of customer contracts and reducing demand through operational productivity and energy efficiency. Large customer contracts typically have escalation and pass-through clauses to recover energy and feedstock costs. Such attempts may not successfully mitigate cost variability which could negatively impact its financial condition or results of operations. The supply of energy has not been a significant issue in the geographic areas where it conducts business. However, regional energy conditions are unpredictable and may pose future risk.
For carbon dioxide, carbon monoxide, helium, hydrogen, specialty gases and surface technologies, raw materials are largely purchased from outside sources. Where feasible, Praxair sources several of these gases, including carbon dioxide, hydrogen and calcium carbide, as chemical or industrial by products. In addition, Praxair has contracts or commitments for, or readily available sources of, most of these raw materials; however, their long-term availability and prices are subject to market conditions. A disruption in supply of such raw materials could impact the company’s ability to meet contractual supply commitments.
International Events and Circumstances - The company’s international operations are subject to the risks of doing business abroad and international events and circumstances may adversely impact its business, financial condition or results of operations.

Praxair has substantial international operations which are subject to risks including devaluations in currency exchange rates, transportation delays and interruptions, political and economic instability and disruptions, restrictions on the transfer of funds, the imposition of duties and tariffs, import and export controls, changes in governmental policies, labor unrest, possible nationalization and/or expropriation of assets, domestic and international tax laws and compliance with governmental regulations. These events could have an adverse effect on the international operations in the future by reducing the demand for its products, decreasing the prices at which it can sell its products, reducing the U.S. dollar value of revenue from international operations or otherwise having an adverse effect on its business. Also, the Company is monitoring developments regarding the collectability of government receivables from healthcare sales to public hospitals in Spain and Italy where economic conditions have been challenging and uncertain. Historically, collection of such government receivables has extended beyond the contractual terms of sale; however, payment has always been received. At March 31, 2015 government receivables in Spain and Italy totaled $66 million ($60 million at December 31, 2014).

43


Global Financial Markets Conditions - Macroeconomic factors may impact the company’s ability to obtain financing or increase the cost of obtaining financing which may adversely impact the company’s financial results and/or cash flows.
Volatility and disruption in the U.S. and global credit and equity markets, from time to time, could make it more difficult for Praxair to obtain financing for its operations and/or could increase the cost of obtaining financing. In addition, the company’s borrowing costs can be affected by short and long-term debt ratings assigned by independent rating agencies which are based, in significant part, on the company’s performance as measured by certain criteria such as interest coverage and leverage ratios. A decrease in these debt ratings could increase the cost of borrowing or make it more difficult to obtain financing. While the impact of volatility in the global credit markets cannot be predicted with certainty, the company believes that it has sufficient operating flexibility, cash reserves, and funding sources to maintain adequate amounts of liquidity to meet its business needs around the world.
Competitor Actions - The inability to effectively compete could adversely impact results of operations.
Praxair operates within a highly competitive environment worldwide. Competition is based on price, product quality, delivery, reliability, technology and service to customers. Competitors’ behavior related to these areas could potentially have significant impacts on the company’s financial results.
Governmental Regulations - The company is subject to a variety of United States and foreign government regulations. Changes in these regulations could have an adverse impact on the business, financial position and results of operations.
The company is subject to regulations in the following areas, among others:
Environmental protection including climate change;
Domestic and international tax laws and currency controls;
Safety;
Securities laws (e.g., SEC and generally accepted accounting principles in the United States);
Trade and import/ export restrictions;
Antitrust matters;
Global anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
Healthcare reimbursement regulations; and
Conflict minerals
Changes in these or other regulatory areas may impact the company’s profitability, may require the company to spend additional resources to comply with the regulations, or may restrict the company’s ability to compete effectively in the marketplace. Noncompliance with such laws and regulations could result in penalties or sanctions that could have an adverse impact on the company’s financial results. Environmental protection is discussed further below.
Praxair is subject to various environmental and occupational health and safety laws and regulations, including those governing the discharge of pollutants into the air or water, the storage, handling and disposal of chemicals, hazardous substances and wastes, the remediation of contamination, the regulation of greenhouse gas emissions, and other potential climate change initiatives. Violations of these laws could result in substantial penalties, third party claims for property damage or personal injury, or sanctions. The company may also be subject to liability for the investigation and remediation of environmental contamination at properties that it owns or operates and at other properties where Praxair or its predecessors have operated or arranged for the disposal of hazardous wastes. Although management does not believe that any such liabilities will have a material adverse impact on its financial position and results of operations, management cannot provide assurance that such costs will not increase in the future or will not become material. See the section captioned “Management’s Discussion and Analysis – Environmental Matters” in Item 7 of Praxair’s 2014 Annual Report on Form 10-K.
Catastrophic Events - Catastrophic events could disrupt the operations of the company and/or its customers and suppliers and may have a significant adverse impact on the results of operations.
The occurrence of catastrophic events or natural disasters such as extreme weather, including hurricanes and floods; health epidemics; acts of war or terrorism; could disrupt or delay the company’s ability to produce and distribute its products to customers and could potentially expose the company to third-party liability claims. In addition, such events could impact the company’s customers and suppliers resulting in temporary or long-term outages and/or the limitation of supply of energy and other raw materials used in normal business operations. To mitigate these risks, Praxair evaluates the direct and indirect business risks; consults with vendors, insurance providers and industry experts; makes investments in suitably resilient design

44


and technology, and conducts regular reviews of the business risks with management. Despite these steps, however, these situations are outside the company’s control and may have a significant adverse impact on the company’s financial results.
Retaining Qualified Personnel - The inability to attract and retain qualified personnel may adversely impact the company’s business.
If Praxair fails to attract, hire and retain qualified personnel, the company may not be able to develop, market or sell its products or successfully manage its business. Praxair is dependent upon its highly skilled, experienced and efficient workforce to be successful. Much of Praxair’s competitive advantage is based on the expertise and experience of its key personnel regarding its marketing, technology, manufacturing and distribution infrastructure, systems and products. The inability to attract and hire qualified individuals or the loss of key employees in very skilled areas could have a negative effect on the company’s financial results.
Technological Advances - If the company fails to keep pace with technological advances in the industry or if new technology initiatives do not become commercially accepted, customers may not continue to buy the company’s products and results of operations could be adversely affected.
Praxair’s research and development is directed toward developing new and improved methods for the production and distribution of industrial gases and the development of new markets and applications for the use of these gases. This results in the frequent introduction of new industrial gas applications and the development of new advanced air separation process technologies. The company also conducts research and development for its surface technologies to improve the quality and durability of coatings and the use of specialty powders for new applications and industries. As a result of these efforts, the company develops new and proprietary technologies and employs necessary measures to protect such technologies within the global geographies in which the company operates. These technologies help Praxair to create a competitive advantage and to provide a platform for the company to grow its business. If Praxair’s research and development activities do not keep pace with competitors or if it does not create new technologies that benefit customers, future results of operations could be adversely affected.
Litigation and Governmental Investigations - The outcomes of litigation and governmental investigations may affect the company’s financial results.
Praxair is subject to various lawsuits and governmental investigations arising out of the normal course of business that may result in adverse outcomes. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Adverse outcomes in some or all of the claims pending may result in significant monetary damages or injunctive relief that could adversely affect its ability to conduct business. While management currently believes that resolving all of these matters, individually or in the aggregate, will not have a material adverse impact on the company’s financial position or liquidity, the litigation and other claims Praxair faces are subject to inherent uncertainties and management’s view of these matters may change in the future. There exists the possibility of a material adverse impact on the company’s results of operations for the period in which the effect of an unfavorable final outcome becomes probable and reasonably estimable.
Tax Liabilities - Potential tax liabilities could adversely impact the company’s financial position and results of operations.
Praxair is subject to income and other taxes in both the United States and numerous foreign jurisdictions. The determination of the company’s worldwide provision for income taxes and other tax liabilities requires judgment and is based on diverse legislative and regulatory structures that exist in the various jurisdictions where the company operates. Although management believes its estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in its financial statements and may materially affect the company’s financial results for the period when such determination is made. See Notes 5 and 17 to the consolidated financial statements of Praxair’s 2014 Annual Report on Form 10-K.
Pension Liabilities - Risks related to our pension benefit plans may adversely impact our results of operations and cash flows.
Pension benefits represent significant financial obligations that will be ultimately settled in the future with employees who meet eligibility requirements. Because of the uncertainties involved in estimating the timing and amount of future payments and asset returns, significant estimates are required to calculate pension expense and liabilities related to the company’s plans. The company utilizes the services of independent actuaries, whose models are used to facilitate these calculations. Several key assumptions are used in the actuarial models to calculate pension expense and liability amounts recorded in the consolidated financial statements. In particular, significant changes in actual investment returns on pension assets, discount rates, or legislative or regulatory changes could impact future results of operations and required pension contributions. For information regarding the potential impacts regarding significant assumptions used to estimate pension expense, including discount rates and the expected long-term rates of return on plan assets. See “Critical Accounting Policies - Pension Benefits” included in

45


“Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of Praxair’s 2014 Annual Report on Form 10-K.
Operational Risks - Operational risks may adversely impact the company’s business or results of operations.
Praxair’s operating results are dependent on the continued operation of its production facilities and its ability to meet customer contract requirements and other needs. Insufficient or excess capacity threatens the company’s ability to generate competitive profit margins and may expose the company to liabilities related to contract commitments. Operating results are also dependent on the company’s ability to complete new construction projects on time, on budget and in accordance with performance requirements. Failure to do so may expose the business to loss of revenue, potential litigation and loss of business reputation.
Also inherent in the management of the company’s production facilities and delivery systems, including storage, vehicle transportation and pipelines, are operational risks that require continuous training, oversight and control. Material operating failures at production, storage facilities or pipelines, including fire, toxic release and explosions, or the occurrence of vehicle transportation accidents could result in loss of life, damage to the environment, loss of production and/or extensive property damage, all of which may negatively impact the company’s financial results.
Information Technology Systems – The Company may be subject to information technology system ("IT") failures, network disruptions and breaches in data security.
Praxair relies on IT systems and networks for business and operational activities, and also stores and processes sensitive business and proprietary information in these systems and networks. These systems are susceptible to outages due to fire, floods, power loss, telecommunications failures, viruses, break-ins and similar events, or breaches of security. Management has taken steps to address these risks and concerns by implementing advanced security technologies, internal controls, network and data center resiliency and recovery processes. Despite these steps, however, operational failures and breaches of security from increasingly sophisticated cyber threats could lead to the loss or disclosure of confidential information, result in regulatory actions and have a material adverse impact on Praxair's operations, reputation and financial results.
Acquisitions and Joint Ventures - The inability to effectively integrate acquisitions or collaborate joint venture partners could adversely impact the company’s financial position and results of operations.
Praxair has evaluated, and expects to continue to evaluate, a wide array of potential strategic acquisitions and joint ventures. Many of these transctions, if consummated, could be material to its financial condition and results of operations. In addition, the process of integrating an acquired company, business or group of assets may create unforeseen operating difficulties and expenditures. Although historically the company has been successful with its acquisition strategy and execution, the areas where the company may face risks include:
The need to implement or remediate controls, procedures and policies appropriate for a larger public company at companies that prior to the acquisition lacked these controls, procedures and policies;
Diversion of management time and focus from operating existing business to acquisition integration challenges;
Cultural challenges associated with integrating employees from the acquired company into the existing organization;
The need to integrate each company’s accounting, management information, human resource and other administrative systems to permit effective management;
Difficulty with the assimilation of acquired operations and products;
Failure to achieve targeted synergies; and
Inability to retain key employees and business relationships of acquired companies.
Foreign acquisitions and joint ventures involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures and languages, currency risks and the particular economic, political and regulatory risks associated with specific countries. Also, the anticipated benefit of the company’s acquisitions may not materialize. Future acquisitions or dispositions could result in potentially dilutive issuances of equity securities, the incurrence of debt, contingent liabilities or amortization expenses, or impairments of goodwill, any of which could adversely impact the company’s financial results.

46


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities- Certain information regarding purchases made by or on behalf of the company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of its common stock during the quarter ended March 31, 2015 is provided below:
Period
Total Number
of Shares
Purchased
(Thousands)
 
Average
Price Paid
Per Share
 
Total Numbers of Shares
Purchased as Part of
Publicly Announced
Program (1) 
(Thousands)
 
Approximate Dollar
Value of Shares that
May Yet be Purchased
Under the Program (2)
(Millions)
January 2015
668

 
$
124.94

 
668

 
$
955

February 2015
516

 
$
125.27

 
516

 
$
890

March 2015
695

 
$
124.05

 
695

 
$
804

First Quarter 2015
1,879

 
$
124.70

 
1,879

 
$
804

 
(1)
On January 28, 2014, the company's board of directors approved the repurchase of $1.5 billion of its common stock (2014 program) which could take place from time to time on the open market (which could include the use of 10b5-1 trading plans) or through negotiated transactions, subject to market and business conditions.
(2)
As of March 31, 2015, the Company purchased $696 million of its common stock pursuant to the 2014 program, leaving an additional $804 million remaining authorized under the 2014 program. The 2014 program does not have any stated expiration date.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
Item 6. Exhibits
(a)
Exhibits
 
 
 
 
 
 
 
12.01
  
Computation of Ratio of Earnings to Fixed Charges.
 
 
 
 
31.01
  
Rule 13a-14(a) Certification
 
 
 
 
31.02
  
Rule 13a-14(a) Certification
 
 
 
 
32.01
  
Section 1350 Certification (such certifications are furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act).
 
 
 
 
32.02
  
Section 1350 Certification (such certifications are furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act).
 
 
 
 
101.INS
  
XBRL Instance Document
 
 
 
 
101.SCH
  
XBRL Taxonomy Extension Schema
 
 
 
 
101.CAL
  
XBRL Taxonomy Extension Calculation Linkbase
 
 
 
 
101.LAB
  
XBRL Taxonomy Extension Label Linkbase
 
 
 
 
101.PRE
  
XBRL Taxonomy Extension Presentation Linkbase
 
 
 
 
101.DEF
  
XBRL Taxonomy Extension Definition Linkbase
*    Indicates a management contract or compensatory plan or arrangement.

47


SIGNATURE
Praxair, Inc. and Subsidiaries
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
PRAXAIR, INC.
 
 
 
 
 
 
(Registrant)
 
 
 
 
Date: April 29, 2015
 
By: /s/ Elizabeth T. Hirsch
 
 
 
 
 
 
Elizabeth T. Hirsch
 
 
 
Vice President and Controller
 
 
 
(On behalf of the Registrant
 
 
 
and as Chief Accounting Officer)
 

48